CA2208705A1 - Stabilization of liquid enzyme compositions - Google Patents
Stabilization of liquid enzyme compositionsInfo
- Publication number
- CA2208705A1 CA2208705A1 CA002208705A CA2208705A CA2208705A1 CA 2208705 A1 CA2208705 A1 CA 2208705A1 CA 002208705 A CA002208705 A CA 002208705A CA 2208705 A CA2208705 A CA 2208705A CA 2208705 A1 CA2208705 A1 CA 2208705A1
- Authority
- CA
- Canada
- Prior art keywords
- enzyme
- composition
- inhibitor
- liquid
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 193
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 149
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 149
- 239000007788 liquid Substances 0.000 title claims abstract description 92
- 230000006641 stabilisation Effects 0.000 title description 4
- 238000011105 stabilization Methods 0.000 title description 4
- 239000003599 detergent Substances 0.000 claims abstract description 82
- 238000004851 dishwashing Methods 0.000 claims abstract description 16
- 239000013037 reversible inhibitor Substances 0.000 claims abstract description 5
- 238000010412 laundry washing Methods 0.000 claims abstract description 4
- 229940088598 enzyme Drugs 0.000 claims description 139
- 239000003112 inhibitor Substances 0.000 claims description 86
- 108091005804 Peptidases Proteins 0.000 claims description 40
- 102000035195 Peptidases Human genes 0.000 claims description 39
- 239000004365 Protease Substances 0.000 claims description 34
- 108090001060 Lipase Proteins 0.000 claims description 20
- 102000004882 Lipase Human genes 0.000 claims description 19
- 239000004367 Lipase Substances 0.000 claims description 19
- 235000019421 lipase Nutrition 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 12
- 239000002532 enzyme inhibitor Substances 0.000 claims description 11
- 102000004316 Oxidoreductases Human genes 0.000 claims description 10
- 108090000854 Oxidoreductases Proteins 0.000 claims description 10
- 229940125532 enzyme inhibitor Drugs 0.000 claims description 10
- 229940025131 amylases Drugs 0.000 claims description 8
- UYANAUSDHIFLFQ-UHFFFAOYSA-N borinic acid Chemical class OB UYANAUSDHIFLFQ-UHFFFAOYSA-N 0.000 claims description 8
- 125000005620 boronic acid group Chemical group 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 102000013142 Amylases Human genes 0.000 claims description 6
- 108010065511 Amylases Proteins 0.000 claims description 6
- 108010084185 Cellulases Proteins 0.000 claims description 6
- 102000005575 Cellulases Human genes 0.000 claims description 6
- 235000019418 amylase Nutrition 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 24
- 238000010348 incorporation Methods 0.000 abstract 1
- -1 Iipases Proteins 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 24
- 230000005764 inhibitory process Effects 0.000 description 24
- 235000019419 proteases Nutrition 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 18
- 230000002441 reversible effect Effects 0.000 description 18
- 239000002253 acid Chemical class 0.000 description 17
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 17
- 239000004327 boric acid Substances 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 108010020132 microbial serine proteinases Proteins 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 11
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 11
- 229910052708 sodium Inorganic materials 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 150000001412 amines Chemical class 0.000 description 9
- 239000007844 bleaching agent Substances 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 8
- 102000003992 Peroxidases Human genes 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 7
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 7
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 6
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 6
- 239000007818 Grignard reagent Substances 0.000 description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 6
- 239000005642 Oleic acid Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 6
- 150000004795 grignard reagents Chemical class 0.000 description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 6
- 239000002736 nonionic surfactant Substances 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 6
- 239000001509 sodium citrate Substances 0.000 description 6
- 150000003573 thiols Chemical class 0.000 description 6
- 108700020962 Peroxidase Proteins 0.000 description 5
- 108090000787 Subtilisin Proteins 0.000 description 5
- 108010056079 Subtilisins Proteins 0.000 description 5
- 102000005158 Subtilisins Human genes 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000007046 ethoxylation reaction Methods 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 description 5
- VJOWMORERYNYON-UHFFFAOYSA-N 5-ethenyl-2-methylpyridine Chemical compound CC1=CC=C(C=C)C=N1 VJOWMORERYNYON-UHFFFAOYSA-N 0.000 description 4
- 108010059892 Cellulase Proteins 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 229960004106 citric acid Drugs 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 125000003107 substituted aryl group Chemical group 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 4
- DKYRKAIKWFHQHM-UHFFFAOYSA-N (3,5-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=CC(Cl)=C1 DKYRKAIKWFHQHM-UHFFFAOYSA-N 0.000 description 3
- IBTSWKLSEOGJGJ-UHFFFAOYSA-N (3-acetamidophenyl)boronic acid Chemical compound CC(=O)NC1=CC=CC(B(O)O)=C1 IBTSWKLSEOGJGJ-UHFFFAOYSA-N 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical class 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- 108010029541 Laccase Proteins 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 125000002950 monocyclic group Chemical group 0.000 description 3
- HUMMCEUVDBVXTQ-UHFFFAOYSA-N naphthalen-1-ylboronic acid Chemical class C1=CC=C2C(B(O)O)=CC=CC2=C1 HUMMCEUVDBVXTQ-UHFFFAOYSA-N 0.000 description 3
- 125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 229920000196 poly(lauryl methacrylate) Polymers 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000151 polyglycol Polymers 0.000 description 3
- 239000010695 polyglycol Substances 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 150000004760 silicates Chemical class 0.000 description 3
- 229910052911 sodium silicate Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000010457 zeolite Substances 0.000 description 3
- QBLFZIBJXUQVRF-UHFFFAOYSA-N (4-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Br)C=C1 QBLFZIBJXUQVRF-UHFFFAOYSA-N 0.000 description 2
- JFCLNCVCDFUJPO-UHFFFAOYSA-N (5-chlorothiophen-2-yl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)S1 JFCLNCVCDFUJPO-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- XSVSPKKXQGNHMD-UHFFFAOYSA-N 5-bromo-3-methyl-1,2-thiazole Chemical compound CC=1C=C(Br)SN=1 XSVSPKKXQGNHMD-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 229910011255 B2O3 Inorganic materials 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010008488 Glycylglycine Proteins 0.000 description 2
- 102100027612 Kallikrein-11 Human genes 0.000 description 2
- 229940127470 Lipase Inhibitors Drugs 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- LEMABCWCFKCYQC-UHFFFAOYSA-N OBO.C1=CC=CC2=CC=CC=C21 Chemical class OBO.C1=CC=CC2=CC=CC=C21 LEMABCWCFKCYQC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 239000004115 Sodium Silicate Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- 101710152431 Trypsin-like protease Proteins 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 230000003625 amylolytic effect Effects 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical group OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 150000001642 boronic acid derivatives Chemical class 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000001461 cytolytic effect Effects 0.000 description 2
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 2
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 229940043257 glycylglycine Drugs 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000003752 hydrotrope Substances 0.000 description 2
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Chemical compound Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000002366 lipolytic effect Effects 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 238000006138 lithiation reaction Methods 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 125000003703 phosphorus containing inorganic group Chemical group 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 2
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000003890 succinate salts Chemical class 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- DGUWACLYDSWXRZ-UHFFFAOYSA-N (2-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1C=O DGUWACLYDSWXRZ-UHFFFAOYSA-N 0.000 description 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- HJBGZJMKTOMQRR-UHFFFAOYSA-N (3-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C=O)=C1 HJBGZJMKTOMQRR-UHFFFAOYSA-N 0.000 description 1
- SNJANQMHRGSHFN-UHFFFAOYSA-N (6-hydroxynaphthalen-2-yl)boronic acid Chemical compound C1=C(O)C=CC2=CC(B(O)O)=CC=C21 SNJANQMHRGSHFN-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- CENMEJUYOOMFFZ-UHFFFAOYSA-N 1,3,2-benzodioxaborole Chemical compound C1=CC=C2OBOC2=C1 CENMEJUYOOMFFZ-UHFFFAOYSA-N 0.000 description 1
- BFSNEBVTOODGHZ-UHFFFAOYSA-N 1-bromo-4-(diethoxymethyl)benzene Chemical compound CCOC(OCC)C1=CC=C(Br)C=C1 BFSNEBVTOODGHZ-UHFFFAOYSA-N 0.000 description 1
- DLKQHBOKULLWDQ-UHFFFAOYSA-N 1-bromonaphthalene Chemical compound C1=CC=C2C(Br)=CC=CC2=C1 DLKQHBOKULLWDQ-UHFFFAOYSA-N 0.000 description 1
- TYKPJLVEPXWTFW-UHFFFAOYSA-N 3,7,9-trichloro-1-isocyanopurine-2,6,8-trione Chemical compound ClN1C(=O)N([N+]#[C-])C(=O)C2=C1N(Cl)C(=O)N2Cl TYKPJLVEPXWTFW-UHFFFAOYSA-N 0.000 description 1
- MSOSPLTZVVLJDB-FQEVSTJZSA-N 3-[[5-[[(2s)-1-carboxy-4-[(2-chlorophenyl)methylsulfanyl]-3-oxobutan-2-yl]carbamoyl]thiophen-2-yl]methylsulfamoyl]benzoic acid Chemical compound N([C@@H](CC(=O)O)C(=O)CSCC=1C(=CC=CC=1)Cl)C(=O)C(S1)=CC=C1CNS(=O)(=O)C1=CC=CC(C(O)=O)=C1 MSOSPLTZVVLJDB-FQEVSTJZSA-N 0.000 description 1
- XCMISAPCWHTVNG-UHFFFAOYSA-N 3-bromothiophene Chemical compound BrC=1C=CSC=1 XCMISAPCWHTVNG-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- KFHKERRGDZTZQJ-HHHVGSORSA-N Acarviosin Chemical group O[C@@H]1[C@@H](O)[C@@H](OC)O[C@H](C)[C@H]1N[C@H]1[C@@H](O)[C@H](O)[C@@H](O)C(CO)=C1 KFHKERRGDZTZQJ-HHHVGSORSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- KNMZUYRTYPXGDH-UHFFFAOYSA-N BrC12NC(NC1(NC(N(C2=O)[N+]#[C-])=O)Br)=O Chemical compound BrC12NC(NC1(NC(N(C2=O)[N+]#[C-])=O)Br)=O KNMZUYRTYPXGDH-UHFFFAOYSA-N 0.000 description 1
- LRRDOTYFRDWULQ-UHFFFAOYSA-N BrN1C(N(C=2N(C(N(C(C1=2)=O)[N+]#[C-])=O)Br)Br)=O Chemical compound BrN1C(N(C=2N(C(N(C(C1=2)=O)[N+]#[C-])=O)Br)Br)=O LRRDOTYFRDWULQ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- 244000251987 Coprinus macrorhizus Species 0.000 description 1
- 241000204401 Craterellus cinereus Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102100031375 Endothelial lipase Human genes 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000205003 Methanothrix thermoacetophila Species 0.000 description 1
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- JLNMSNDDYBZCIB-UHFFFAOYSA-N OOOOS Chemical compound OOOOS JLNMSNDDYBZCIB-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710115215 Protease inhibitors Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930092411 Swietenocoumarin D Natural products 0.000 description 1
- 241000222354 Trametes Species 0.000 description 1
- 240000001274 Trichosanthes villosa Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 229960001413 acetanilide Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003392 amylase inhibitor Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001543 aryl boronic acids Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- ZDQWVKDDJDIVAL-UHFFFAOYSA-N catecholborane Chemical compound C1=CC=C2O[B]OC2=C1 ZDQWVKDDJDIVAL-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000009990 desizing Methods 0.000 description 1
- MCBDXMRLVTYWJJ-UHFFFAOYSA-N dichloroborane methylsulfanylmethane Chemical compound CSC.ClBCl MCBDXMRLVTYWJJ-UHFFFAOYSA-N 0.000 description 1
- CEJLBZWIKQJOAT-UHFFFAOYSA-N dichloroisocyanuric acid Chemical class ClN1C(=O)NC(=O)N(Cl)C1=O CEJLBZWIKQJOAT-UHFFFAOYSA-N 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- ZHXTWWCDMUWMDI-UHFFFAOYSA-N dihydroxyboron Chemical compound O[B]O ZHXTWWCDMUWMDI-UHFFFAOYSA-N 0.000 description 1
- VIGVRXYWWFPORY-UHFFFAOYSA-N diphenylborinic acid Chemical compound C=1C=CC=CC=1B(O)C1=CC=CC=C1 VIGVRXYWWFPORY-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 108010091371 endoglucanase 1 Proteins 0.000 description 1
- 108010091384 endoglucanase 2 Proteins 0.000 description 1
- 108010092450 endoglucanase Z Proteins 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000002979 fabric softener Substances 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007999 glycylglycine buffer Substances 0.000 description 1
- PMYUVOOOQDGQNW-UHFFFAOYSA-N hexasodium;trioxido(trioxidosilyloxy)silane Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-] PMYUVOOOQDGQNW-UHFFFAOYSA-N 0.000 description 1
- LERLVVJWRNTZMD-UHFFFAOYSA-N hexasodium;trioxido(trioxidosilyloxy)silane;hydrate Chemical compound O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-] LERLVVJWRNTZMD-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 108010065073 lidase Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- KTMKRRPZPWUYKK-UHFFFAOYSA-N methylboronic acid Chemical compound CB(O)O KTMKRRPZPWUYKK-UHFFFAOYSA-N 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- CBLJNXZOFGRDAC-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)octadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+]([O-])(CCO)CCO CBLJNXZOFGRDAC-UHFFFAOYSA-N 0.000 description 1
- DIKJPMZHWIMKJK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide;dihydrate Chemical compound O.O.CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] DIKJPMZHWIMKJK-UHFFFAOYSA-N 0.000 description 1
- KPTRDYONBVUWPD-UHFFFAOYSA-N naphthalen-2-ylboronic acid Chemical compound C1=CC=CC2=CC(B(O)O)=CC=C21 KPTRDYONBVUWPD-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000006965 reversible inhibition Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910001483 soda nepheline Inorganic materials 0.000 description 1
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- GIPRGFRQMWSHAK-UHFFFAOYSA-M sodium;2-propan-2-ylbenzenesulfonate Chemical compound [Na+].CC(C)C1=CC=CC=C1S([O-])(=O)=O GIPRGFRQMWSHAK-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 1
- QNMBSXGYAQZCTN-UHFFFAOYSA-N thiophen-3-ylboronic acid Chemical compound OB(O)C=1C=CSC=1 QNMBSXGYAQZCTN-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38618—Protease or amylase in liquid compositions only
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38654—Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38663—Stabilised liquid enzyme compositions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Detergent Compositions (AREA)
Abstract
A liquid, enzyme-containing composition which is well suited, e.g., for subsequent incorporation into a multi-component composition, such as a liquid detergent composition for laundry washing or dishwashing, comprises: (i) an enzyme in an amount exceeding 40 µM; and (ii) a reversible inhibitor of the enzyme in an amount effective to enhance the storage stability of the enzyme in a multi-component composition into which the liquid composition is subsequently incorporated.
Description
CA 0220870~ 1997-06-2~
WO 96/21716 PCTIDK~''., _CS
STArll I7~TION OF LIQUID ENZYME COMPOSITIONS
FIELD OF THE INVENTION
The present invention relates, interalia, to liquid enzyme compositions containing (i) one or more enzymes in from relatively high to very high concentration, and 5 (ii) one or more appropriate enzyme inhibitors, more particularly reversible inhibitors, which exhibit strong enzyme-inhibitory properties and/or which are present at a concentration such as to cause strong enzyme inhibition.
The invention further relates to:
an enzyme-containing, multi-component composition, such a liquid composition, 10 e.g. a cleaning composition such as a detergent composition, prepared using an inhibitor-stabilized liquid enzyme composition of the invention as the source ofenzyme;
a process for preparing an enzyme-containing, multi-component composition, such as a cleaning composition, e.g. a detergent composition, wherein the 5 enzyme(s) in question is/are introduced in the form of an inhibitor-stabilized liquid enzyme composition of the invention, i.e. the enzymes(s) is/are in the form of an inhibitor-stabilized cornposition when incorporated into the multi-component composition; and an enzyme-containing, multi-component composition, such as a cleaning 20 composition, e.g. a detergent composition, prepared by a process of the latter type.
The invention moreo~er relates to the use of a liquid enzyme composition according to the inv0ntion in the preparation or manufacture of an enzyme-CA 0220870~ 1997-06-2 WO 96/21716 PCT/I)K9"~~~~
containing, multi-component composition, such as a cleaning composition, e.g.
a detergent composition. r BACKGROUND OF THE INVENTION
Storage stability problems are well known in connection with liquid compositions5 containing enzymes. Thus, for example, a major problem with enzyme-containing liquid detergents, such as liquid detergents containing a protease (peptidase), is that of ensuring retention of adequate enzyme activity during storage.
Considerable effort has been devoted to finding ways of improving the storage stability of enzyme-containing compositions, e.g. Iiquid compositions such as 0 liquid detergents, for example by adding a protease inhibitor to compositions containing a protease.
The discussion in the remainder of this section relates, by way of illustration,predominantly to inhibition of proteases, but the underlying principles are equally applicable to other types of enzymes, e.g. Iipases, amylases, cellulases and 15 oxidoreductases (such as peroxidases and oxidases), and the various aspects of the present invention are in no way limited to aspects associated with stabilization of proteases by (reversible) protease inhibitors.
By way of example, boric acid and boronic acids are known to reversibly inhibit proteolytic enzymes. A discussion of the inhibition of a serine protease, subtilisin, 20 by boronic acid is given in Molecular & Cellular Biochemistry 51, 1983, pp. 5-32.
Boronic acids have very different capacities as subtilisin inhibitors. Boronic acids containing only alkyl groups such as methyl, butyl or 2-cyclohexylethyl are poorinhibitors, with methylboronic acid being the poorest inhibitor. However, boronic acids bearing aromatic groups such as phenyl, 4-methoxyphenyl or 3,5-25 dichlorophenyl are described as being very good inhibitors, with 3,5-dichlorophenylboronic acid as a particularly effective one (see Keller et al, Biochem. Bioohvs. Res. Comm. 176, 1991, pp. 401-405).
CA 0220870~ 1997-06-2~
WO 96121716 PCT/I)K~ ,C5 It is also claimed, in WO 92/19707, that aryl boronic acids which are substituted at the 3-position of the aryl group relative to boron are unexpectedly good reversible protease inhibitors. Thus, for example, "acetamidobenzene boronic acid" is described in the latter document as being a particularly effective inhibitor 5 of proteolytic enzymes.
When quantifying the inhibitory effect of a reversible enzyme inhibitor, the so-called "inhibition constant" (K;) is ordinarily used as a measure of capacity toinhibit enzyme activity, K; normally being defined as follows:
K; = [E] ~ [I]/[EI]
10 where [E], [I] and [El] denote equilibrium concentrations (conventionally molar concentrations) of enzyme, inhibitor and enzyme-inhibitor complex, respectively,under the conditions in question. The latter definition of K; is employed in thepresent specification and claims. Thus, a relatively low K; value is indicative of a relatively potent inhibitor.
In the preparation or manufacture of multi-component enzyme-containing compositions it will be desirable to employ, as source of enzyme, a pre-preparedenzyme composition containing enzyme(s) and appropriate (reversible) enzyme inhibitor(s). It will be particularly convenient and advantageous that the pre-20 prepared enzyme composition contains a very high concentration of at least oneenzyme, and possibly of several enzymes of the type(s) in question, since this will, among other things, enable the preparation of large volumes or quantities of an enzyme-containing, multi-component composition using relatively small volumes or quantities of pre-prepared enzyme/inhibitor composition.
25 Furthermore, it will clearly be an advantage that satisfactory stability of the enzyme(s) during storage of the final multi-component composition is ensured CA 0220870~ 1997-06-2 WO 96/21716 PCT/DK96'~
solely by the presence of the enzyme inhibitor(s) in question in the amount(s) in which they have been introduced in the form of the original pre-prepared enzyme/inhibitor composition, i.e. that inclusion of further stabilizing agent in the multi-component composition (e.g. a detergent composition) is unnecessary 5 (although further stabilization agents may, of course, be incorporated if so desired) .
Moreover, in such a pre-prepared enzyme/inhibitor composition, the stability of the enzyme(s) for which an inhibitor is present will, in the nature of things, be expected to be high. Thus, numerous pre-prepared compositions of this type will 0 be expected to be capable of storage for relatively prolonged periods of time a~ter manufacture without significant - or at least without unacceptable - loss of enzymatic activity.
The present invention thus relates to a liquid composition comprising: (i) an enzyme in an amount exceeding 40 IJM; and (ii) a reversible enzyme inhibitor in 15 an amount effective to enhance the storage stability of the enzyme in a multi-component composition (e.g. a detergent composition, such as a liquid detergent composition) into which the liquid composition is subsequently incorporated.
A liquid composition of the invention may, for example, be a predominantly aqueous composition, or a predominantly non-aqueous composition (e.g. a 20 composition comprising as solvent a high proportion of one or more non-aqueous - but normally water-miscible - liquids, generally organic liquids (such as alcohols, glycols or the like). Liquid compositions of the invention will themselves normally be non-detergent compositions.
Apart from detergent compositions (e.g. for laundry washing, dishwashing and 25 the like), other types of enzyme-containing, multi-component compositions, notably in the form of liquid compositions, which are of relevance in the context of the present invention include: compositions for cleaning dentures, contact lenses or hard surfaces (e.g. in slaughterhouses, or in the food processing CA 0220870~ 1997-06-25 W O96/21716 PCTADh~-'00005 industry); compositions for use in l:he leather industry (e g. for de-hairing and/or de-fatting of animal hides); compositions for desizing textiles; and compositions for washing denim l:extiles to achieve a "stone-washed" appearance. The use of such compositions for such purposes is within the scope of the invention.
5 Enzvmes Enzyme classification numbers (EC numbers) referred to in the present specification with claims are in accordance with the Recommendations (1992) of the Nomenclature Committee of the International Union of Biochemistrv and Molecular Biology, Academic Press Inc., 1992.
10 A liquid composition of the invention contains at least one enzyme. Suitable enzymes include any commercially available enzyme. Particularly relevant enzymes include en;~ymes selected from the group consisting of proteases (i.e.
peptidases, EC 3.4), amylases (classified under EC 3.2.1), lipases (including those classified under EC 3.1.1.3), cellulases (including EC 3.2.1.4) and 15 oxidoreductases (EC, 1), e.g. peroxidases (EC 1 .1 1 ) and oxidases [including enzymes classified under EC 1.10.3, such as laccases (EC 1.10.3.2)], and any mixture thereof. Mixtures of enzymes from the same class (e.g. mixtures of different proteases, different lipases, etc.) are also included.
The amount(s) of enzyme(s) in the liquid composition will vary according to the 20 type of enzyme(s) and the intended use of the liquid composition. In general, any enzyme present will preferably be present in an amount in the range of 0.2-50 %
by weight (w/w) of the liquid composition (calculated on the basis of pure enzyme protein), often 0.5-25 % w/w, such as 1-10% w/w, e.g. 2-8% w/w of the liquid composition. Expressed in concentration units, a preferred 25 concentration range for an enzyme present in a liquid composition of the invention will be from about 50 ,uM to about 20 mM, often from 100 ~M to 10 mM, such as from 5()0 ~M to 5 mM, e.g. from 750 ,uM to 3 mM (calculated on the basis of moles of pure enzyme protein).
CA 02208705 1997-06-2~
W O96121716 PCT~DK~f~S
Proteases. Any protease (proteolytic enzyme) suitable for use in a liquid composition can be used. Suitable proteases include those of animal, vegetable or microbial origin, especially microbial origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or 5 more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit proteolytic activity. The protease may, e.g., be a serine peptidase, preferably an alkaline microbial protease or a trypsin-like protease. Examples of alkaline proteases are subtilisins, especially those derived from Bacillus, e.g. subtilisin 0 Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in W0 89/06279). Examples of commercial Bacillus subtilisins are Alcalase~, SavinaselM, EsperaselM and Durazym~ products, all available from NovoNordisk A/S. A number of these protease products, such as Alcalase~, Esperase~
and SavinasenA, are available as liquids (e.g. Savinase~ 16.0 L, Type DX and Type EX) which are well suited (vide infra) to the preparation of protease-containingliquid compositions according to the present invention.
Examples of trypsin-like proteases include trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in W0 89/06270.
Amvlases. Any amylase (amylolytic enzyme) suitable for use in a liquid 20 composition can be used. Suitable amylases include those of bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit amylolytic activity.
25 Amylases include, for example, a-amylases (EC 3.2.1.1), e.g. obtained from a particular strain of B. Iicheniformis, described in more detail in British Patent Specification No. 1,296,839. A very suitable a-amylase is TermamyllU, which is available (inter alia as a liquid product) from Novo Nordisk A/S.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK~G~?~~--5 Lipases. Any lipase (lipolytic enzyme) suitable for use in a liquid composition can be used. Suitable lipases include those of bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted 5 and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit lipolytic activity. A very suitable lipase is that obtained by cloning the gene from Humicola lanuqinosa and expressing the gene in Aspergillus orvzae, as described in EP 0 258 068, which is available (interalia as a liquid product) from Novo Nordisk A/S under the tradename Lipolase~.
0 Cellulases. Any cellulase (cellulolytic enzyme) suitable for use in a liquid composition can be used. Suitable cellulases include those of bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of a 15 enzyme of one of the latter types, and which exhibit cellulolytic activity. Suitable cellulases are disclosed, for example, in US 4,435,307. A very suitable cellulase is that produced by a strain of Humicola insolens, available from Novo Nordisk A/S under the tradename Celluzyme~.
Peroxidases. Any peroxidase suitable for use in a liquid composition, e.g. Iiquid 20 detergent composition, can be used. Suitable peroxidases herein include those of plant, bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the aminoacid sequence of an 0nzyme of one of the latter types, and which exhibit 25 peroxidase activity. Examples of suitable peroxidases are those derived from a strain of Coprinus (e.g. C. cinerius or C. macrorhizus) or from a strain of Bacillus (e.g. B. oumilus), particularly a peroxidase according to PCT/DK90/00260.
Oxidases. Any oxidase suitable for use in a liquid composition, e.g. Iiquid detergent composition, can be used. Suitable oxidases herein include those of CA 0220870~ 1997-06-25 W O 96/21716 PCT~Dh~6/0000S
bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit oxidase 5 activity. Examples of suitable oxidases are laccases derived from strains of AsPerqillus, Neurospora (e.g. N. crassa), Trametes (e.g. T. villosa) or MvcelioPhthora (e.g. M. thermoPhila).
Enzvme inhibitors (enzvme stabilizers) A liquid composition according to the invention contains at least one reversible10 enzyme inhibitor, normally one which is an inhibitor for at least one enzyme present in the liquid composition. Thus, for example, a liquid composition of the invention may, in addition to containing a first type of enzyme and a reversibleinhibitor for that type of enzyme, contain a second, third...etc. type of enzyme(e.g. an enzyme of one of the types mentioned above) one or more of which is 15 not accompanied by a reversible inhibitor therefor.
It should be mentioned here that it is perfectly feasible to prepare a liquid enzyme composition which contains one or more enzymes, in amounts as disclosed herein, but which instead of containing an inhibitor for one or more of these enzymes contains an inhibitor for another type of enzyme with which the liquid 20 composition may subsequently be contacted. One example hereof would be a liquid composition containing, as the only enzyme, a lipase together with a protease inhibitor; the protease inhibitor would then protect the lipase with respect to degradation by a protease which - deliberately or inadvertently - maysubsequently be brought into contact with the lipase.
25 The nature and amount(s) of the inhibitor(s) employed will depend, in~eralia, on the nature and concentration of the enzyme(s) present in the composition, and on the intended use of the composition. This is discussed further below.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK~ 5 With respect to rever~iible inhibitors (and associated Kj values therefor) of relevance for use in connection with various classes/types of enzymes which may be present in a liquid composition of the invention, reference is made to: H.
Zollner, Handbook of E nzyme Inhibitors (Parts A and B), 2nd edition, VCH
5 Verlagsgesellschaft mbH, Weinheim, Germany, 1993, for an extensive listing.
Further sources of relevance include: S. Patkar and F. Bjorkling, LiPase inhibitors, in: Li~ases - their Structure. Biochemistry and Ac~lication. Editors P. Woolley and S.B. Petersen, Cambridge University Press, Cambridge 1994. Selected examples of relevant types of reversible inhibitors are the following:
0 Protease inhibitors. One particularly interesting class of reversible proteaseinhibitors is constitutecl by the boronic acids [R'B(OH)2] and borinic acids [R'R''B(OH)] (where R' and R'' are organic substituents, e.g. optionally substituted aryl or heterocyclic substituents), some examples of which have beenmentioned above. Further examples of relevant compounds of this type may be 15 selected among those mentioned in WO 92/19707, in EP 0 478 050 A1 and in EP0511 456A1.
Interesting compounds of this type may be found among those described in WO 95/02046 (which was unpublished at the priority date of the present application), and which c:omprise compounds of the following general formula:
R, - (R2)n- B - OH
I
25 where R1 is an optionally substituted fused aromatic ring structure containing 14 or 18 carbon atoms in the ring, or an optionally substituted monocyclic or fusedaromatic heterocyclic ring structure containing up to 17 carbon atoms in the ring, or an optionally substituted monocyclic or fused quinonoid ring structure containing up to 18 carbon atoms in the ring;
-CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K~ ~r R2 has the formula:
CH ~o I C=C ~p ~ CH ~ q 5 where X is the same or different and selected from hydrogen, C,-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, hydroxy, hydroxyl derivative, halogen, amine, alkylated amine, amine derivative, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate, and o, p and q may be the same or different and may each be 0, 1 or 2;
10 m and n may be the same or different and may each be 0 or 1;
R3 is the same or different as R1 and selected from R1, or R3 is a hydroxyl group, or R~ and R3 are both optionally substituted monocyclic or dicyclic aromatic ring structures.
In the above context, optionally substituted ring structures are such that the 15 substituents on the ring structure are freely chosen, but they are preferablyselected from hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, hydroxy, hydroxyl derivative, halogen, amine, alkylated amine, amine derivative,nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate .
20 Boronic and borinic acid derivatives may be prepared using methods well knownto those skilled in the art, for example by using one of the following methods:
a) Hydroboration of unsaturated materials, i.e. alkenes and alkynes, using either catecholborane (1,3,2-benzodioxaborole) or dichloroborane-dimethyl-sulphide complex as the hydroborating agent; for reference see H.C.Brown, S.K.Gupta in 25 IACS 97, 1975, pp. 5249-5255 and H.C.Brown, N.Ravindran, S.U.Kuikarni in 1. Org.Chem . 45, (1980), p. 384.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK9G/0~~~;
b) The reaction of a Grignard reagent with either tri-n-butylborate or trimethylborate, followed by hydrolysis of the boronic ester thus formed; for reference see F.R.Bean, J.R. Johnson in Jacs 54, 1932, pp. 4415-4425 and S.H.Dandegaonher, S.P.lngleshwar in Journal of Shivasi Universitv 6, 1932, pp.
5 11-13. Bromo-substituted starting materials that are not commercially available may be prepared conveniently in two steps from the corresponding carboxylic acids by reduction with LiAlH4, followed by treatment with CBr4.
c) The reaction of an organolithium reagent with butylborate; for reference see S.O.Lauesson, pp. 387-:395 in Thiophene Chemistrv, Part 7, and D.Florentin, 10 B.Roques in C.R.Acad.Sci.Paris, t.270 (11 May 1970), pp. 1608-1610.
d) Borinic acid derivatives may be prepared according to method b, above.
However, the ratio of Grignard reagent to borate adopted is then 2:1.
e) Any nuclear substitution or protection of functional groups is achieved by using standard methods ~vell known to those skilled in the art.
15 Further interesting compounds of this type may be selected among naphthalene boronic acids which are clescribed in WO 95/29223 (which was unpublished at the priority date of the present application) and which comprise compounds having the following general formulas:
6 ~ or R7 B (OH) z R~4 R~3 Rs~ Rz ( O~ ) z R7 R~
CA 0220870~ 1997-06-2~
where R" R2, R3, R4, R5, R6 and R7 are the same or different and are selected from hydrogen, C1 C6 alkyl, substituted C1-CG alkyl, aryl, substituted aryl, hydroxy, hydroxyl derivative, halogen, amine, alkylated amine, amine derivative,nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phos-5 phonate.
Naphthalene boronic acid derivatives may be likewise be prepared using methods well known to those skilled in the art, for example by using a Grignard preparation as follows:
The Grignard reagent is prepared by the slow dropwise addition of the appropriate 10 bromonaphthalene starting material in sodium dried ether to magnesium turningin sodium dried ether. The reaction is promoted by the addition of a small iodine crystal.
Trimethylborate or tri-n-butylborate in sodium dried ether is cooled to -70~C, and the Grignard reagent is added dropwise over a period of 2 hours while keeping 15 the organoborate solution at -70~C and continuously agitating. The reaction mixture is allowed to warm to room temperature overnight, whereupon it is hydrolysed by the dropwise addition of cold dilute sulphuric acid. The ether layer is separated and the aqueous layer extracted with ether. The ether-containing fractions are combined and the solvent removed. The residue is made strongly 20 alkaline, and any methanol or butanol so formed is removed. The alkaline solution is cooled and the resulting crystals of the desired boronic acid are removed by filtration. All products are preferably recrystallized from distilled water.
The naphthalene boronic acids may also be prepared using either direct lithiation of the naphthalene and/or lithiation of the bromide.
25 Any nuclear substitution or protection of functional groups may be achieved by using standard methods well known to those skilled in the art.
CA 0220870~ 1997-06-2 WO 96/21716 PCTlI)K9' Among compounds of the above-mentioned types, specific boronic acids of interest in the context of the invention include the following: benzofuran-2-boronic acid; phenyl-boronic acid; 4-bromophenyl-boronic acid; 4-formylphenyl-boronic acid; 3-acetamidophenyl-boronic acid; 3,5-dichlorophenyl-boronic acid;
5 5-chlorothiophene-2-boronic acid; naphthalene-1-boronic acid; naphthalene-2-boronic acid; and 6-hydroxynaphthalene-2-boronic acid. Further specific compounds of this type which are of interest in the context of the invention arementioned in the table given in Example 2 herein (vide infra).
Inhibitors of the boronic or borinic acid type may be introduced or incorporated0 into liquid compositions of the invention in the form of the acids themselves (e.g.
dissolved in an appropriate water-miscible organic solvent, such as mono-propylene glycol or the like), or, if appropriate (e.g. for solubility reasons), as salts (e.g. alkali metal salts, such as sodium or potassium salts).
Reversible amvlase inhibitors. Reversible amylase inhibitors of possible relevance 15 in the context of the invention may be found, e.g., among compounds of the so-called "acarbose" type (i.e. pseudo-oligosaccharides containing an acarviosine moiety and one or more maltose units). Other compounds of relevance as inhibitors for, in particular, a-amylases include maltose and maltotriose.
Compounds such as methyl-a-glucoside, as well as cycloamyloses, e.g.
20 cyclohexa- and/or cycloheptaamylose, may be of relevance as reversible inhibitors for ,B-amylases.
Reversible cellulase inhibitors. Reversible cellulase inhibitors of potential interest - in the context of the invention include 4-thiol-cellooligosaccharides [see, e.g., C. Schou et al., Journal of Carbohydrate Chemistrv 12 (1993) pp. 743-752].
A
25 Reversible liDase inhibitors. Reversible lipase inhibitors of relevance in the context of the invention include boronic and borinic acids selected among those described above and/or mentioned below (such as, e.g., optionally substituted phenyl boronic acids).
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K9G/000 5 Degree of enzYme inhibition The desired degree ~strength, extent) of inhibition of an enzyme present in a liquid composition according to the invention will depend, among other things, on the purpose for which the composition is intended. In general, the molar ratio 5 of reversible inhibitor to enzyme will be chosen to be such that at least about one inhibitor molecule is present per active site of the enzyme in question, which will of course require a molar ratio of inhibitor (I) to enzyme (E) of at least 1:1. For certain purposes a lower l:E molar ratio, e.g. about 0.8:1, about 0.7:1, about 0.6:1 or even about 0.5:1, may, however, be appropriate. However, in the 10 context of the invention it will generally be desirable to employ a molar ratio of inhibitor to enzyme of at least 5, such as at least 15. In certain cases, I:E molar ratios of at least 50 or at least 100, or even higher ratios, may be appropriate.
The molar ratio of inhibitor to enzyme will be chosen, inter a/ia, on the basis of considerations relating to the percentage of free (uninhibited) enzyme which it is desired to have present during the actual use of a multi-component, enzyme-containing composition based on a liquid composition of the invention. Thus, forexample, when using a laundry detergent composition for laundry washing, it willclearly be a requisite that a satisfactorily high level of free enzyme (e.g. a protease or a lipase) is present in the washing medium (which is typically water20 to which the the detergent composition in question has been added).
In this connection a parameter of importance is the inhibition constant (definedabove) for reversible inhibition of an enzyme. Thus, for example, when a liquid composition of the invention is to be in a detergent composition, the inhibitionconstant (K;), expressed in the conventional manner in mol/l (M), for a reversible 25 inhibitor of an enzyme therein will often suitably be such that 3 ~ 1 o-8 M ' K; ' 1.2 ~ 1 o-2 M, such as 3 ~ 1 o-8 M ~ K; c 1 ~ 1 o-2 M. A more desirable "window of inhibition" in connection with detergent enzymes will, however, often be such that an inhibitor(s) associated with a particular enzyme exerts an inhibition CA 0220870~ 1997-06-2~
WO 96/21716 PcT/DK9~ 5 correspondingto about '3-1O-7 M ~ K~ 1O-3 M, such as 4.3 ~ 1O-7 M ~ K; c 4.5-10-4 M.
In general, preferred enzyme-containing liquid compositions of the invention arecompositions in which the ratio between:
5 (a) the total molar concentration (which may be denoted [I]t) of a reversible enzyme inhibitor, I, present in the composition; and (b) the inhibition constant (Kj; expressed in mol/l) for inhibition of an enzymewhich is present in the composition and which is reversibly inhibited by the inhibitor in question;
10 is at least 50 (i.e. [I]t/Kj ~- 50), such as at least 100 or, frequently, at least 250.
A practical upper limit for the ratio [I]t/Kj in liquid compositions of the invention will normally be about 10000 (i.e. 1 O4). For many purposes, a value for the ratio [I]t/K; in the range of 250-5000, often in the range of 250-2500, will be appropriate .
The value of the ratio [l~t/Ki may be regarded as a measure of the "inhibitory capacity" of a liquid composition of the invention. A high value - and thereby ahigh "inhibitory capacity" - may be achieved, for example, by incorporating, in a liquid composition, a re3atively modes~ to low concentration of a strongly inhibiting inhibitor, or by incorporating a relatively high concentration of a more 20 weakly inhibiting inhibitor.
In the presence of a relatively large molar excess of the inhibitor, I, relative to the inhibited enzyme, E, the major proportion of the inhibitor will normally be in free form, i.e. will not be bound to enzyme. Denoting the concentration of free (unbound) inhibitor by [I] (as in connection with Kj; vide supr~), the ratio rl]t/K;
25 will then be approximately equal to ~he ratio [I]/Kj, i.e. [I]t/Kj ~ [I]/K; under such conditions.
It may be mentioned here that liquid compositions according to the invention, comprising enzyme(s) and reversible enzyme inhibitor(s), may be dried by CA 0220870~ 1997-06-2 WO 96t21716 PCT/DK~)G/C~
appropriate methods (e.g. by Iyophilization or by spray-drying. The dried enzyme/inhibitor product may be then be comminuted (e.g. by milling) and suspended or slurried at an appropriate concentration in a non-aqueous liquid vehicle, e.g. a non-ionic surfactant (such as SoftanollM from BP), to form a slurry 5 product.
Detergents For detergent compositions, a typical goal will be attainment of at least 50%
inhibition of a chosen enzyme (e.g. a protease) in the detergent composition perse, and an amount of free enzyme in the washing medium corresponding to at 10 least 50% of the total amount of that enzyme.
A detergent composition incorporating a liquid composition of the invention will, apart from enzyme(s) and inhibitor(s), comprise a surfactant, and will normally be a liquid detergent composition. The detergent composition may, e.g., be a laundry detergent composition or a dishwashing detergent composition.
15 A liquid detergent composition may be aqueous, e.g. typically containing up to 70% of water and 0-30% of organic solvent, or substantially non-aqueous.
The detergent composition will comprise one or more surfactants, each of which may be anionic, nonionic, cationic, or amphoteric (zwitterionic). The detergent will usually contain 0-50% of anionic surfactant such as linear alkylbenzene-20 sulfonate (I~AS), alpha-olefinsulfonate (AOS), alkyl sulfate (fatty alcohol sulfate) (AS), alcohol ethoxysulfate (AEOS or AES), secondary alkanesulfonates (SAS), alpha-sulfo fatty acid methyl esters, alkyl- or alkenylsuccinic acid, or soap. It may also contain 0-40% of nonionic surfactant such as alcohol ethoxylate (AEO or AE), alcohol propoxylate, carboxylated alcohol ethoxylates, nonylphenol 25 ethoxylate, alkylpolyglycoside, alkyldimethylamine oxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, or polyhydroxy alkyl fatty acid amide (e.g. as described in WO 92/06154).
_ CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96/00005 Normally the detergent contains 1-65 % of a detergent builder, but some dishwashing detergents may contain even up to 90% of a detergent builder, or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, citrate, nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), 5 diethylenetriaminepentaacetic acid (DTMPA), alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
The detergent builders may be subdivided into phosphorus-containing and non-phosphorous-containing types. Examples of phosphorus-containing inorganic alkaline detergent builders include the water-soluble salts, especially alkali metal 0 pyrophosphates, orthophosphates, polyphosphates and phosphonates. Examples of non-phosphorus-containing inorganic builders include water-soluble alkali metal carbonates, borates and silicates as well as layered disilicates and the varioustypes of water-insoluble crystalline or amorphous alumino silicates of which zeolites is the best known representative.
15 Examples of suitable organic builders include alkali metal, ammonium or substituted ammonium salts of succinates, malonates, fatty acid malonates, fattyacid sulphonates, carbloxymethoxy succinates, polyacetates, carboxylates, polycarboxylates, aminopolycarboxylates and polyacetyl carboxylates. The detergent may also be unbuilt, i.e. essentially free of detergent builder.
20 The detergent may comprise one or more polymers. Examples are carboxymethylcellulose (CMC), poly(vinylpyrrolidone) (PVP), polyethyleneglycol (PEG), poly(vinyl alcohol) (PVA), polycarboxylates such as polyacrylates, - polymaleates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers .
25 The detergent composition may contain bleaching agents of the chlorine/bromine-type or the oxygen-type. The bleaching agents may be coated or encapsulated.
Examples of inorganic chlorine/bromine-type bleaches are lithium, sodium or calcium hypochlorite or hypobromite as well as chlorinated trisodium phosphate.
CA 0220870~ 1997-06-2~
WO 96/21716 PCTlDEV-'O~:lOS
The bleaching system may also comprise a H2O2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine (TAED) or nonanoyloxybenzenesulfonate (NOBS) .
5 Examples of organic chlorine/bromine-type bleaches are heterocyclic N-bromo and N-chloro imides such as trichloroisocyanuric, tribromoisocyanuric, dibromoisocyanuric and dichloroisocyanuric acids, and salts thereof with water solubilizing cations such as potassium and sodium. Hydantoin compounds are also suitable. The bleaching system may also comprise peroxyacids of, e.g., the 10 amide, imide, or sulfone type;
In dishwashing detergents the oxygen bleaches are preferred, for example in the form of an inorganic persalt, preferably with a bleach precursor or as a peroxy acid compound. Typical examples of suitable peroxy bleach compounds are alkali metal perborates, both tetrahydrates and monohydrates, alkali metal 15 percarbonates, persilicates and perphosphates. Preferred activator materials are TAED or NOBS.
As already mentioned, the enzymes of the detergent composition of the invention are incorporated in the detergent composition in the form of a liquid enzyme/inhibitor composition according to the invention.
20 If so desired, further conventional enzyme-stabilizing substances may be incorporated, e.g. a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative such as an aromaticborate ester (see, e.g., WO 92/19709 and WO 92/19708).
The detergent may also contain other conventional detergent ingredients such as,25 e.g., fabric conditioners including clays, deflocculant material, foam boosters/foam depressors (in dishwashing detergents foam depressors), suds CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96/00005 suppressors, anti-corrosion agents, soil-suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides, optical brighteners, or perfume.
The pH (measured in aqueous solution at use concentration) will usually be neutral or alkaline, e.g. in the range of 7-11.
5 Particular forms of laundry detergent compositions within the scope of the invention include:
1) An aqueous liquid detergent composition comprising Linear alkylbenzenesulfonate (calculated as 15 - 21%
acid) 0 Alcohol ethoxylate (e.g. C1215 alcohol, 7 E0 or C12 15 alcohol, 5 E0) 1 2 - 1 8%
Soap as fatty acid (e.g. oleic acid) 3 - 13%
Alkenylsuccinic acid (C12 14) ~ - 13%
Aminoethanol 8 - 18%
Citric acid 2 - 8%
Phosphonate 0 - 3%
Polymers (e.g. PVP, PE--G) 0 - 3%
Borate (as B407) ~ - 2%
Ethanol 0 - 3 %
Propylene glycol 8 - 14%
Enzymes (calculated as pure enzyme 0.0001 - 0.2%
protein) - Minor ingredients (e.g. dispersants, suds suppressors, perfume, optical brightener) 0 - 5%
CA 0220870~ l997-06-2 WO 96/2171G PCT/I)K~)G~
WO 96/21716 PCTIDK~''., _CS
STArll I7~TION OF LIQUID ENZYME COMPOSITIONS
FIELD OF THE INVENTION
The present invention relates, interalia, to liquid enzyme compositions containing (i) one or more enzymes in from relatively high to very high concentration, and 5 (ii) one or more appropriate enzyme inhibitors, more particularly reversible inhibitors, which exhibit strong enzyme-inhibitory properties and/or which are present at a concentration such as to cause strong enzyme inhibition.
The invention further relates to:
an enzyme-containing, multi-component composition, such a liquid composition, 10 e.g. a cleaning composition such as a detergent composition, prepared using an inhibitor-stabilized liquid enzyme composition of the invention as the source ofenzyme;
a process for preparing an enzyme-containing, multi-component composition, such as a cleaning composition, e.g. a detergent composition, wherein the 5 enzyme(s) in question is/are introduced in the form of an inhibitor-stabilized liquid enzyme composition of the invention, i.e. the enzymes(s) is/are in the form of an inhibitor-stabilized cornposition when incorporated into the multi-component composition; and an enzyme-containing, multi-component composition, such as a cleaning 20 composition, e.g. a detergent composition, prepared by a process of the latter type.
The invention moreo~er relates to the use of a liquid enzyme composition according to the inv0ntion in the preparation or manufacture of an enzyme-CA 0220870~ 1997-06-2 WO 96/21716 PCT/I)K9"~~~~
containing, multi-component composition, such as a cleaning composition, e.g.
a detergent composition. r BACKGROUND OF THE INVENTION
Storage stability problems are well known in connection with liquid compositions5 containing enzymes. Thus, for example, a major problem with enzyme-containing liquid detergents, such as liquid detergents containing a protease (peptidase), is that of ensuring retention of adequate enzyme activity during storage.
Considerable effort has been devoted to finding ways of improving the storage stability of enzyme-containing compositions, e.g. Iiquid compositions such as 0 liquid detergents, for example by adding a protease inhibitor to compositions containing a protease.
The discussion in the remainder of this section relates, by way of illustration,predominantly to inhibition of proteases, but the underlying principles are equally applicable to other types of enzymes, e.g. Iipases, amylases, cellulases and 15 oxidoreductases (such as peroxidases and oxidases), and the various aspects of the present invention are in no way limited to aspects associated with stabilization of proteases by (reversible) protease inhibitors.
By way of example, boric acid and boronic acids are known to reversibly inhibit proteolytic enzymes. A discussion of the inhibition of a serine protease, subtilisin, 20 by boronic acid is given in Molecular & Cellular Biochemistry 51, 1983, pp. 5-32.
Boronic acids have very different capacities as subtilisin inhibitors. Boronic acids containing only alkyl groups such as methyl, butyl or 2-cyclohexylethyl are poorinhibitors, with methylboronic acid being the poorest inhibitor. However, boronic acids bearing aromatic groups such as phenyl, 4-methoxyphenyl or 3,5-25 dichlorophenyl are described as being very good inhibitors, with 3,5-dichlorophenylboronic acid as a particularly effective one (see Keller et al, Biochem. Bioohvs. Res. Comm. 176, 1991, pp. 401-405).
CA 0220870~ 1997-06-2~
WO 96121716 PCT/I)K~ ,C5 It is also claimed, in WO 92/19707, that aryl boronic acids which are substituted at the 3-position of the aryl group relative to boron are unexpectedly good reversible protease inhibitors. Thus, for example, "acetamidobenzene boronic acid" is described in the latter document as being a particularly effective inhibitor 5 of proteolytic enzymes.
When quantifying the inhibitory effect of a reversible enzyme inhibitor, the so-called "inhibition constant" (K;) is ordinarily used as a measure of capacity toinhibit enzyme activity, K; normally being defined as follows:
K; = [E] ~ [I]/[EI]
10 where [E], [I] and [El] denote equilibrium concentrations (conventionally molar concentrations) of enzyme, inhibitor and enzyme-inhibitor complex, respectively,under the conditions in question. The latter definition of K; is employed in thepresent specification and claims. Thus, a relatively low K; value is indicative of a relatively potent inhibitor.
In the preparation or manufacture of multi-component enzyme-containing compositions it will be desirable to employ, as source of enzyme, a pre-preparedenzyme composition containing enzyme(s) and appropriate (reversible) enzyme inhibitor(s). It will be particularly convenient and advantageous that the pre-20 prepared enzyme composition contains a very high concentration of at least oneenzyme, and possibly of several enzymes of the type(s) in question, since this will, among other things, enable the preparation of large volumes or quantities of an enzyme-containing, multi-component composition using relatively small volumes or quantities of pre-prepared enzyme/inhibitor composition.
25 Furthermore, it will clearly be an advantage that satisfactory stability of the enzyme(s) during storage of the final multi-component composition is ensured CA 0220870~ 1997-06-2 WO 96/21716 PCT/DK96'~
solely by the presence of the enzyme inhibitor(s) in question in the amount(s) in which they have been introduced in the form of the original pre-prepared enzyme/inhibitor composition, i.e. that inclusion of further stabilizing agent in the multi-component composition (e.g. a detergent composition) is unnecessary 5 (although further stabilization agents may, of course, be incorporated if so desired) .
Moreover, in such a pre-prepared enzyme/inhibitor composition, the stability of the enzyme(s) for which an inhibitor is present will, in the nature of things, be expected to be high. Thus, numerous pre-prepared compositions of this type will 0 be expected to be capable of storage for relatively prolonged periods of time a~ter manufacture without significant - or at least without unacceptable - loss of enzymatic activity.
The present invention thus relates to a liquid composition comprising: (i) an enzyme in an amount exceeding 40 IJM; and (ii) a reversible enzyme inhibitor in 15 an amount effective to enhance the storage stability of the enzyme in a multi-component composition (e.g. a detergent composition, such as a liquid detergent composition) into which the liquid composition is subsequently incorporated.
A liquid composition of the invention may, for example, be a predominantly aqueous composition, or a predominantly non-aqueous composition (e.g. a 20 composition comprising as solvent a high proportion of one or more non-aqueous - but normally water-miscible - liquids, generally organic liquids (such as alcohols, glycols or the like). Liquid compositions of the invention will themselves normally be non-detergent compositions.
Apart from detergent compositions (e.g. for laundry washing, dishwashing and 25 the like), other types of enzyme-containing, multi-component compositions, notably in the form of liquid compositions, which are of relevance in the context of the present invention include: compositions for cleaning dentures, contact lenses or hard surfaces (e.g. in slaughterhouses, or in the food processing CA 0220870~ 1997-06-25 W O96/21716 PCTADh~-'00005 industry); compositions for use in l:he leather industry (e g. for de-hairing and/or de-fatting of animal hides); compositions for desizing textiles; and compositions for washing denim l:extiles to achieve a "stone-washed" appearance. The use of such compositions for such purposes is within the scope of the invention.
5 Enzvmes Enzyme classification numbers (EC numbers) referred to in the present specification with claims are in accordance with the Recommendations (1992) of the Nomenclature Committee of the International Union of Biochemistrv and Molecular Biology, Academic Press Inc., 1992.
10 A liquid composition of the invention contains at least one enzyme. Suitable enzymes include any commercially available enzyme. Particularly relevant enzymes include en;~ymes selected from the group consisting of proteases (i.e.
peptidases, EC 3.4), amylases (classified under EC 3.2.1), lipases (including those classified under EC 3.1.1.3), cellulases (including EC 3.2.1.4) and 15 oxidoreductases (EC, 1), e.g. peroxidases (EC 1 .1 1 ) and oxidases [including enzymes classified under EC 1.10.3, such as laccases (EC 1.10.3.2)], and any mixture thereof. Mixtures of enzymes from the same class (e.g. mixtures of different proteases, different lipases, etc.) are also included.
The amount(s) of enzyme(s) in the liquid composition will vary according to the 20 type of enzyme(s) and the intended use of the liquid composition. In general, any enzyme present will preferably be present in an amount in the range of 0.2-50 %
by weight (w/w) of the liquid composition (calculated on the basis of pure enzyme protein), often 0.5-25 % w/w, such as 1-10% w/w, e.g. 2-8% w/w of the liquid composition. Expressed in concentration units, a preferred 25 concentration range for an enzyme present in a liquid composition of the invention will be from about 50 ,uM to about 20 mM, often from 100 ~M to 10 mM, such as from 5()0 ~M to 5 mM, e.g. from 750 ,uM to 3 mM (calculated on the basis of moles of pure enzyme protein).
CA 02208705 1997-06-2~
W O96121716 PCT~DK~f~S
Proteases. Any protease (proteolytic enzyme) suitable for use in a liquid composition can be used. Suitable proteases include those of animal, vegetable or microbial origin, especially microbial origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or 5 more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit proteolytic activity. The protease may, e.g., be a serine peptidase, preferably an alkaline microbial protease or a trypsin-like protease. Examples of alkaline proteases are subtilisins, especially those derived from Bacillus, e.g. subtilisin 0 Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in W0 89/06279). Examples of commercial Bacillus subtilisins are Alcalase~, SavinaselM, EsperaselM and Durazym~ products, all available from NovoNordisk A/S. A number of these protease products, such as Alcalase~, Esperase~
and SavinasenA, are available as liquids (e.g. Savinase~ 16.0 L, Type DX and Type EX) which are well suited (vide infra) to the preparation of protease-containingliquid compositions according to the present invention.
Examples of trypsin-like proteases include trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in W0 89/06270.
Amvlases. Any amylase (amylolytic enzyme) suitable for use in a liquid 20 composition can be used. Suitable amylases include those of bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit amylolytic activity.
25 Amylases include, for example, a-amylases (EC 3.2.1.1), e.g. obtained from a particular strain of B. Iicheniformis, described in more detail in British Patent Specification No. 1,296,839. A very suitable a-amylase is TermamyllU, which is available (inter alia as a liquid product) from Novo Nordisk A/S.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK~G~?~~--5 Lipases. Any lipase (lipolytic enzyme) suitable for use in a liquid composition can be used. Suitable lipases include those of bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted 5 and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit lipolytic activity. A very suitable lipase is that obtained by cloning the gene from Humicola lanuqinosa and expressing the gene in Aspergillus orvzae, as described in EP 0 258 068, which is available (interalia as a liquid product) from Novo Nordisk A/S under the tradename Lipolase~.
0 Cellulases. Any cellulase (cellulolytic enzyme) suitable for use in a liquid composition can be used. Suitable cellulases include those of bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of a 15 enzyme of one of the latter types, and which exhibit cellulolytic activity. Suitable cellulases are disclosed, for example, in US 4,435,307. A very suitable cellulase is that produced by a strain of Humicola insolens, available from Novo Nordisk A/S under the tradename Celluzyme~.
Peroxidases. Any peroxidase suitable for use in a liquid composition, e.g. Iiquid 20 detergent composition, can be used. Suitable peroxidases herein include those of plant, bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the aminoacid sequence of an 0nzyme of one of the latter types, and which exhibit 25 peroxidase activity. Examples of suitable peroxidases are those derived from a strain of Coprinus (e.g. C. cinerius or C. macrorhizus) or from a strain of Bacillus (e.g. B. oumilus), particularly a peroxidase according to PCT/DK90/00260.
Oxidases. Any oxidase suitable for use in a liquid composition, e.g. Iiquid detergent composition, can be used. Suitable oxidases herein include those of CA 0220870~ 1997-06-25 W O 96/21716 PCT~Dh~6/0000S
bacterial and fungal origin, as well as chemically produced or protein engineered (genetically engineered) mutants (variants) in which one or more amino acids have been substituted, inserted and/or deleted relative to the amino acid sequence of an enzyme of one of the latter types, and which exhibit oxidase 5 activity. Examples of suitable oxidases are laccases derived from strains of AsPerqillus, Neurospora (e.g. N. crassa), Trametes (e.g. T. villosa) or MvcelioPhthora (e.g. M. thermoPhila).
Enzvme inhibitors (enzvme stabilizers) A liquid composition according to the invention contains at least one reversible10 enzyme inhibitor, normally one which is an inhibitor for at least one enzyme present in the liquid composition. Thus, for example, a liquid composition of the invention may, in addition to containing a first type of enzyme and a reversibleinhibitor for that type of enzyme, contain a second, third...etc. type of enzyme(e.g. an enzyme of one of the types mentioned above) one or more of which is 15 not accompanied by a reversible inhibitor therefor.
It should be mentioned here that it is perfectly feasible to prepare a liquid enzyme composition which contains one or more enzymes, in amounts as disclosed herein, but which instead of containing an inhibitor for one or more of these enzymes contains an inhibitor for another type of enzyme with which the liquid 20 composition may subsequently be contacted. One example hereof would be a liquid composition containing, as the only enzyme, a lipase together with a protease inhibitor; the protease inhibitor would then protect the lipase with respect to degradation by a protease which - deliberately or inadvertently - maysubsequently be brought into contact with the lipase.
25 The nature and amount(s) of the inhibitor(s) employed will depend, in~eralia, on the nature and concentration of the enzyme(s) present in the composition, and on the intended use of the composition. This is discussed further below.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK~ 5 With respect to rever~iible inhibitors (and associated Kj values therefor) of relevance for use in connection with various classes/types of enzymes which may be present in a liquid composition of the invention, reference is made to: H.
Zollner, Handbook of E nzyme Inhibitors (Parts A and B), 2nd edition, VCH
5 Verlagsgesellschaft mbH, Weinheim, Germany, 1993, for an extensive listing.
Further sources of relevance include: S. Patkar and F. Bjorkling, LiPase inhibitors, in: Li~ases - their Structure. Biochemistry and Ac~lication. Editors P. Woolley and S.B. Petersen, Cambridge University Press, Cambridge 1994. Selected examples of relevant types of reversible inhibitors are the following:
0 Protease inhibitors. One particularly interesting class of reversible proteaseinhibitors is constitutecl by the boronic acids [R'B(OH)2] and borinic acids [R'R''B(OH)] (where R' and R'' are organic substituents, e.g. optionally substituted aryl or heterocyclic substituents), some examples of which have beenmentioned above. Further examples of relevant compounds of this type may be 15 selected among those mentioned in WO 92/19707, in EP 0 478 050 A1 and in EP0511 456A1.
Interesting compounds of this type may be found among those described in WO 95/02046 (which was unpublished at the priority date of the present application), and which c:omprise compounds of the following general formula:
R, - (R2)n- B - OH
I
25 where R1 is an optionally substituted fused aromatic ring structure containing 14 or 18 carbon atoms in the ring, or an optionally substituted monocyclic or fusedaromatic heterocyclic ring structure containing up to 17 carbon atoms in the ring, or an optionally substituted monocyclic or fused quinonoid ring structure containing up to 18 carbon atoms in the ring;
-CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K~ ~r R2 has the formula:
CH ~o I C=C ~p ~ CH ~ q 5 where X is the same or different and selected from hydrogen, C,-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, hydroxy, hydroxyl derivative, halogen, amine, alkylated amine, amine derivative, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate, and o, p and q may be the same or different and may each be 0, 1 or 2;
10 m and n may be the same or different and may each be 0 or 1;
R3 is the same or different as R1 and selected from R1, or R3 is a hydroxyl group, or R~ and R3 are both optionally substituted monocyclic or dicyclic aromatic ring structures.
In the above context, optionally substituted ring structures are such that the 15 substituents on the ring structure are freely chosen, but they are preferablyselected from hydrogen, C1-C6 alkyl, substituted C1-C6 alkyl, aryl, substituted aryl, hydroxy, hydroxyl derivative, halogen, amine, alkylated amine, amine derivative,nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate .
20 Boronic and borinic acid derivatives may be prepared using methods well knownto those skilled in the art, for example by using one of the following methods:
a) Hydroboration of unsaturated materials, i.e. alkenes and alkynes, using either catecholborane (1,3,2-benzodioxaborole) or dichloroborane-dimethyl-sulphide complex as the hydroborating agent; for reference see H.C.Brown, S.K.Gupta in 25 IACS 97, 1975, pp. 5249-5255 and H.C.Brown, N.Ravindran, S.U.Kuikarni in 1. Org.Chem . 45, (1980), p. 384.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK9G/0~~~;
b) The reaction of a Grignard reagent with either tri-n-butylborate or trimethylborate, followed by hydrolysis of the boronic ester thus formed; for reference see F.R.Bean, J.R. Johnson in Jacs 54, 1932, pp. 4415-4425 and S.H.Dandegaonher, S.P.lngleshwar in Journal of Shivasi Universitv 6, 1932, pp.
5 11-13. Bromo-substituted starting materials that are not commercially available may be prepared conveniently in two steps from the corresponding carboxylic acids by reduction with LiAlH4, followed by treatment with CBr4.
c) The reaction of an organolithium reagent with butylborate; for reference see S.O.Lauesson, pp. 387-:395 in Thiophene Chemistrv, Part 7, and D.Florentin, 10 B.Roques in C.R.Acad.Sci.Paris, t.270 (11 May 1970), pp. 1608-1610.
d) Borinic acid derivatives may be prepared according to method b, above.
However, the ratio of Grignard reagent to borate adopted is then 2:1.
e) Any nuclear substitution or protection of functional groups is achieved by using standard methods ~vell known to those skilled in the art.
15 Further interesting compounds of this type may be selected among naphthalene boronic acids which are clescribed in WO 95/29223 (which was unpublished at the priority date of the present application) and which comprise compounds having the following general formulas:
6 ~ or R7 B (OH) z R~4 R~3 Rs~ Rz ( O~ ) z R7 R~
CA 0220870~ 1997-06-2~
where R" R2, R3, R4, R5, R6 and R7 are the same or different and are selected from hydrogen, C1 C6 alkyl, substituted C1-CG alkyl, aryl, substituted aryl, hydroxy, hydroxyl derivative, halogen, amine, alkylated amine, amine derivative,nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phos-5 phonate.
Naphthalene boronic acid derivatives may be likewise be prepared using methods well known to those skilled in the art, for example by using a Grignard preparation as follows:
The Grignard reagent is prepared by the slow dropwise addition of the appropriate 10 bromonaphthalene starting material in sodium dried ether to magnesium turningin sodium dried ether. The reaction is promoted by the addition of a small iodine crystal.
Trimethylborate or tri-n-butylborate in sodium dried ether is cooled to -70~C, and the Grignard reagent is added dropwise over a period of 2 hours while keeping 15 the organoborate solution at -70~C and continuously agitating. The reaction mixture is allowed to warm to room temperature overnight, whereupon it is hydrolysed by the dropwise addition of cold dilute sulphuric acid. The ether layer is separated and the aqueous layer extracted with ether. The ether-containing fractions are combined and the solvent removed. The residue is made strongly 20 alkaline, and any methanol or butanol so formed is removed. The alkaline solution is cooled and the resulting crystals of the desired boronic acid are removed by filtration. All products are preferably recrystallized from distilled water.
The naphthalene boronic acids may also be prepared using either direct lithiation of the naphthalene and/or lithiation of the bromide.
25 Any nuclear substitution or protection of functional groups may be achieved by using standard methods well known to those skilled in the art.
CA 0220870~ 1997-06-2 WO 96/21716 PCTlI)K9' Among compounds of the above-mentioned types, specific boronic acids of interest in the context of the invention include the following: benzofuran-2-boronic acid; phenyl-boronic acid; 4-bromophenyl-boronic acid; 4-formylphenyl-boronic acid; 3-acetamidophenyl-boronic acid; 3,5-dichlorophenyl-boronic acid;
5 5-chlorothiophene-2-boronic acid; naphthalene-1-boronic acid; naphthalene-2-boronic acid; and 6-hydroxynaphthalene-2-boronic acid. Further specific compounds of this type which are of interest in the context of the invention arementioned in the table given in Example 2 herein (vide infra).
Inhibitors of the boronic or borinic acid type may be introduced or incorporated0 into liquid compositions of the invention in the form of the acids themselves (e.g.
dissolved in an appropriate water-miscible organic solvent, such as mono-propylene glycol or the like), or, if appropriate (e.g. for solubility reasons), as salts (e.g. alkali metal salts, such as sodium or potassium salts).
Reversible amvlase inhibitors. Reversible amylase inhibitors of possible relevance 15 in the context of the invention may be found, e.g., among compounds of the so-called "acarbose" type (i.e. pseudo-oligosaccharides containing an acarviosine moiety and one or more maltose units). Other compounds of relevance as inhibitors for, in particular, a-amylases include maltose and maltotriose.
Compounds such as methyl-a-glucoside, as well as cycloamyloses, e.g.
20 cyclohexa- and/or cycloheptaamylose, may be of relevance as reversible inhibitors for ,B-amylases.
Reversible cellulase inhibitors. Reversible cellulase inhibitors of potential interest - in the context of the invention include 4-thiol-cellooligosaccharides [see, e.g., C. Schou et al., Journal of Carbohydrate Chemistrv 12 (1993) pp. 743-752].
A
25 Reversible liDase inhibitors. Reversible lipase inhibitors of relevance in the context of the invention include boronic and borinic acids selected among those described above and/or mentioned below (such as, e.g., optionally substituted phenyl boronic acids).
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K9G/000 5 Degree of enzYme inhibition The desired degree ~strength, extent) of inhibition of an enzyme present in a liquid composition according to the invention will depend, among other things, on the purpose for which the composition is intended. In general, the molar ratio 5 of reversible inhibitor to enzyme will be chosen to be such that at least about one inhibitor molecule is present per active site of the enzyme in question, which will of course require a molar ratio of inhibitor (I) to enzyme (E) of at least 1:1. For certain purposes a lower l:E molar ratio, e.g. about 0.8:1, about 0.7:1, about 0.6:1 or even about 0.5:1, may, however, be appropriate. However, in the 10 context of the invention it will generally be desirable to employ a molar ratio of inhibitor to enzyme of at least 5, such as at least 15. In certain cases, I:E molar ratios of at least 50 or at least 100, or even higher ratios, may be appropriate.
The molar ratio of inhibitor to enzyme will be chosen, inter a/ia, on the basis of considerations relating to the percentage of free (uninhibited) enzyme which it is desired to have present during the actual use of a multi-component, enzyme-containing composition based on a liquid composition of the invention. Thus, forexample, when using a laundry detergent composition for laundry washing, it willclearly be a requisite that a satisfactorily high level of free enzyme (e.g. a protease or a lipase) is present in the washing medium (which is typically water20 to which the the detergent composition in question has been added).
In this connection a parameter of importance is the inhibition constant (definedabove) for reversible inhibition of an enzyme. Thus, for example, when a liquid composition of the invention is to be in a detergent composition, the inhibitionconstant (K;), expressed in the conventional manner in mol/l (M), for a reversible 25 inhibitor of an enzyme therein will often suitably be such that 3 ~ 1 o-8 M ' K; ' 1.2 ~ 1 o-2 M, such as 3 ~ 1 o-8 M ~ K; c 1 ~ 1 o-2 M. A more desirable "window of inhibition" in connection with detergent enzymes will, however, often be such that an inhibitor(s) associated with a particular enzyme exerts an inhibition CA 0220870~ 1997-06-2~
WO 96/21716 PcT/DK9~ 5 correspondingto about '3-1O-7 M ~ K~ 1O-3 M, such as 4.3 ~ 1O-7 M ~ K; c 4.5-10-4 M.
In general, preferred enzyme-containing liquid compositions of the invention arecompositions in which the ratio between:
5 (a) the total molar concentration (which may be denoted [I]t) of a reversible enzyme inhibitor, I, present in the composition; and (b) the inhibition constant (Kj; expressed in mol/l) for inhibition of an enzymewhich is present in the composition and which is reversibly inhibited by the inhibitor in question;
10 is at least 50 (i.e. [I]t/Kj ~- 50), such as at least 100 or, frequently, at least 250.
A practical upper limit for the ratio [I]t/Kj in liquid compositions of the invention will normally be about 10000 (i.e. 1 O4). For many purposes, a value for the ratio [I]t/K; in the range of 250-5000, often in the range of 250-2500, will be appropriate .
The value of the ratio [l~t/Ki may be regarded as a measure of the "inhibitory capacity" of a liquid composition of the invention. A high value - and thereby ahigh "inhibitory capacity" - may be achieved, for example, by incorporating, in a liquid composition, a re3atively modes~ to low concentration of a strongly inhibiting inhibitor, or by incorporating a relatively high concentration of a more 20 weakly inhibiting inhibitor.
In the presence of a relatively large molar excess of the inhibitor, I, relative to the inhibited enzyme, E, the major proportion of the inhibitor will normally be in free form, i.e. will not be bound to enzyme. Denoting the concentration of free (unbound) inhibitor by [I] (as in connection with Kj; vide supr~), the ratio rl]t/K;
25 will then be approximately equal to ~he ratio [I]/Kj, i.e. [I]t/Kj ~ [I]/K; under such conditions.
It may be mentioned here that liquid compositions according to the invention, comprising enzyme(s) and reversible enzyme inhibitor(s), may be dried by CA 0220870~ 1997-06-2 WO 96t21716 PCT/DK~)G/C~
appropriate methods (e.g. by Iyophilization or by spray-drying. The dried enzyme/inhibitor product may be then be comminuted (e.g. by milling) and suspended or slurried at an appropriate concentration in a non-aqueous liquid vehicle, e.g. a non-ionic surfactant (such as SoftanollM from BP), to form a slurry 5 product.
Detergents For detergent compositions, a typical goal will be attainment of at least 50%
inhibition of a chosen enzyme (e.g. a protease) in the detergent composition perse, and an amount of free enzyme in the washing medium corresponding to at 10 least 50% of the total amount of that enzyme.
A detergent composition incorporating a liquid composition of the invention will, apart from enzyme(s) and inhibitor(s), comprise a surfactant, and will normally be a liquid detergent composition. The detergent composition may, e.g., be a laundry detergent composition or a dishwashing detergent composition.
15 A liquid detergent composition may be aqueous, e.g. typically containing up to 70% of water and 0-30% of organic solvent, or substantially non-aqueous.
The detergent composition will comprise one or more surfactants, each of which may be anionic, nonionic, cationic, or amphoteric (zwitterionic). The detergent will usually contain 0-50% of anionic surfactant such as linear alkylbenzene-20 sulfonate (I~AS), alpha-olefinsulfonate (AOS), alkyl sulfate (fatty alcohol sulfate) (AS), alcohol ethoxysulfate (AEOS or AES), secondary alkanesulfonates (SAS), alpha-sulfo fatty acid methyl esters, alkyl- or alkenylsuccinic acid, or soap. It may also contain 0-40% of nonionic surfactant such as alcohol ethoxylate (AEO or AE), alcohol propoxylate, carboxylated alcohol ethoxylates, nonylphenol 25 ethoxylate, alkylpolyglycoside, alkyldimethylamine oxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, or polyhydroxy alkyl fatty acid amide (e.g. as described in WO 92/06154).
_ CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96/00005 Normally the detergent contains 1-65 % of a detergent builder, but some dishwashing detergents may contain even up to 90% of a detergent builder, or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, citrate, nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), 5 diethylenetriaminepentaacetic acid (DTMPA), alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
The detergent builders may be subdivided into phosphorus-containing and non-phosphorous-containing types. Examples of phosphorus-containing inorganic alkaline detergent builders include the water-soluble salts, especially alkali metal 0 pyrophosphates, orthophosphates, polyphosphates and phosphonates. Examples of non-phosphorus-containing inorganic builders include water-soluble alkali metal carbonates, borates and silicates as well as layered disilicates and the varioustypes of water-insoluble crystalline or amorphous alumino silicates of which zeolites is the best known representative.
15 Examples of suitable organic builders include alkali metal, ammonium or substituted ammonium salts of succinates, malonates, fatty acid malonates, fattyacid sulphonates, carbloxymethoxy succinates, polyacetates, carboxylates, polycarboxylates, aminopolycarboxylates and polyacetyl carboxylates. The detergent may also be unbuilt, i.e. essentially free of detergent builder.
20 The detergent may comprise one or more polymers. Examples are carboxymethylcellulose (CMC), poly(vinylpyrrolidone) (PVP), polyethyleneglycol (PEG), poly(vinyl alcohol) (PVA), polycarboxylates such as polyacrylates, - polymaleates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers .
25 The detergent composition may contain bleaching agents of the chlorine/bromine-type or the oxygen-type. The bleaching agents may be coated or encapsulated.
Examples of inorganic chlorine/bromine-type bleaches are lithium, sodium or calcium hypochlorite or hypobromite as well as chlorinated trisodium phosphate.
CA 0220870~ 1997-06-2~
WO 96/21716 PCTlDEV-'O~:lOS
The bleaching system may also comprise a H2O2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine (TAED) or nonanoyloxybenzenesulfonate (NOBS) .
5 Examples of organic chlorine/bromine-type bleaches are heterocyclic N-bromo and N-chloro imides such as trichloroisocyanuric, tribromoisocyanuric, dibromoisocyanuric and dichloroisocyanuric acids, and salts thereof with water solubilizing cations such as potassium and sodium. Hydantoin compounds are also suitable. The bleaching system may also comprise peroxyacids of, e.g., the 10 amide, imide, or sulfone type;
In dishwashing detergents the oxygen bleaches are preferred, for example in the form of an inorganic persalt, preferably with a bleach precursor or as a peroxy acid compound. Typical examples of suitable peroxy bleach compounds are alkali metal perborates, both tetrahydrates and monohydrates, alkali metal 15 percarbonates, persilicates and perphosphates. Preferred activator materials are TAED or NOBS.
As already mentioned, the enzymes of the detergent composition of the invention are incorporated in the detergent composition in the form of a liquid enzyme/inhibitor composition according to the invention.
20 If so desired, further conventional enzyme-stabilizing substances may be incorporated, e.g. a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative such as an aromaticborate ester (see, e.g., WO 92/19709 and WO 92/19708).
The detergent may also contain other conventional detergent ingredients such as,25 e.g., fabric conditioners including clays, deflocculant material, foam boosters/foam depressors (in dishwashing detergents foam depressors), suds CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96/00005 suppressors, anti-corrosion agents, soil-suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides, optical brighteners, or perfume.
The pH (measured in aqueous solution at use concentration) will usually be neutral or alkaline, e.g. in the range of 7-11.
5 Particular forms of laundry detergent compositions within the scope of the invention include:
1) An aqueous liquid detergent composition comprising Linear alkylbenzenesulfonate (calculated as 15 - 21%
acid) 0 Alcohol ethoxylate (e.g. C1215 alcohol, 7 E0 or C12 15 alcohol, 5 E0) 1 2 - 1 8%
Soap as fatty acid (e.g. oleic acid) 3 - 13%
Alkenylsuccinic acid (C12 14) ~ - 13%
Aminoethanol 8 - 18%
Citric acid 2 - 8%
Phosphonate 0 - 3%
Polymers (e.g. PVP, PE--G) 0 - 3%
Borate (as B407) ~ - 2%
Ethanol 0 - 3 %
Propylene glycol 8 - 14%
Enzymes (calculated as pure enzyme 0.0001 - 0.2%
protein) - Minor ingredients (e.g. dispersants, suds suppressors, perfume, optical brightener) 0 - 5%
CA 0220870~ l997-06-2 WO 96/2171G PCT/I)K~)G~
2) An aqueous structured liquid detergent composition comprising Linear alkylbenzenesulfonate (calculated as 1 5 - 21%
Alcohol ethoxylate (e . g . C1 2 1 5 alcohol, 7 or C12 ,5 alcohol, 5 EO) Soap as fatty acid (e.g. oleic acid) 3 - 10%
Zeolite (as NaAlSiO4) 14 - 22%
Potassium citrate 9 - 1 8%
0 Borate (as B4072-) 0 - 2%
Carboxymethylcellulose O - 2%
Polymers (e.g. PEG, PVP) O - 3%
Anchoring polymers such as, e.g., lauryl methacrylate/acrylic acid copolymer; molar O - 3%
5 ratio 25:1; MW 3800 Glycerol o - 5%
Enzymes (calculated as pure enzyme pro- 0.0001 - 0.2%
tein) Minor ingredients ~e.g. dispersants, suds 20 suppressors, perfume, optical brighteners) O - 5%
WO 96/21716 PCTIDK~ DC-~:
Alcohol ethoxylate (e . g . C1 2 1 5 alcohol, 7 or C12 ,5 alcohol, 5 EO) Soap as fatty acid (e.g. oleic acid) 3 - 10%
Zeolite (as NaAlSiO4) 14 - 22%
Potassium citrate 9 - 1 8%
0 Borate (as B4072-) 0 - 2%
Carboxymethylcellulose O - 2%
Polymers (e.g. PEG, PVP) O - 3%
Anchoring polymers such as, e.g., lauryl methacrylate/acrylic acid copolymer; molar O - 3%
5 ratio 25:1; MW 3800 Glycerol o - 5%
Enzymes (calculated as pure enzyme pro- 0.0001 - 0.2%
tein) Minor ingredients ~e.g. dispersants, suds 20 suppressors, perfume, optical brighteners) O - 5%
WO 96/21716 PCTIDK~ DC-~:
3) An aqueous liquid detergent composition comprising Linear alkylbenzenesulfonate (calculated as acid) 1 5 - 23 %
Alcohol ethoxysulfate (e.g. C~2 15 alcohol, 2-3 E0) 8 - 15%
Alcohol ethoxylate (e.g. C,2.15 alcohol, 7 EO, 3 - 9 %
or C,2,5 alcohol, 5 E0) Soap as fatty acid (e.g. Iauric acid) 0 - 3%
Aminoethanol 1 - 5 %
Sodium citrate 5 - 10%
Hydrotrope (e.g. sodium toluensulfonate) 2 - 6%
Borate (as B4072-) 0 - 2%
Carboxymethylcellulose 0 - 1%
Ethanol 1 - 3 %
Propylene glycol 2 - 5%
Enzymes (calculated as pure enzyme pro- 0.0001 - 0.2%
tein) Minor ingredients (e.g. polymers, dispersants, perfume, optical brighteners) 0 - 5%
CA 0220870~ 1997-06-2~
O 9 6 /2 1 7 1 6 P C T/ I ) K 9 4) An aqueous liquid detergent composition comprising Linear alkylbenzenesulfonate (calculated as acid) 20 - 32%
Alcohol ethoxylate (e.g. C12 15 alcohol, 7 E0, or C12 15 alcohol, 5 E0) 6 - 1 2%
Aminoethanol 2 - 6%
Citric acid 8 -1 4%
Borate (as B4072-) 1 - 3%
Polymer (e.g. maleic/acrylic acid copolymer, 0 anchoring polymer such as, e.g., lauryl methacrylate/acrylic acid copolymer) 0 - 3%
Glycerol 3 - 8%
Enzymes (calculated as pure enzyme 0.0001 - 0.2%
protein) Minor ingredients (e.g. hydrotropes, dispersants, perfume, optical brighteners) 0 - 5%
Alcohol ethoxysulfate (e.g. C~2 15 alcohol, 2-3 E0) 8 - 15%
Alcohol ethoxylate (e.g. C,2.15 alcohol, 7 EO, 3 - 9 %
or C,2,5 alcohol, 5 E0) Soap as fatty acid (e.g. Iauric acid) 0 - 3%
Aminoethanol 1 - 5 %
Sodium citrate 5 - 10%
Hydrotrope (e.g. sodium toluensulfonate) 2 - 6%
Borate (as B4072-) 0 - 2%
Carboxymethylcellulose 0 - 1%
Ethanol 1 - 3 %
Propylene glycol 2 - 5%
Enzymes (calculated as pure enzyme pro- 0.0001 - 0.2%
tein) Minor ingredients (e.g. polymers, dispersants, perfume, optical brighteners) 0 - 5%
CA 0220870~ 1997-06-2~
O 9 6 /2 1 7 1 6 P C T/ I ) K 9 4) An aqueous liquid detergent composition comprising Linear alkylbenzenesulfonate (calculated as acid) 20 - 32%
Alcohol ethoxylate (e.g. C12 15 alcohol, 7 E0, or C12 15 alcohol, 5 E0) 6 - 1 2%
Aminoethanol 2 - 6%
Citric acid 8 -1 4%
Borate (as B4072-) 1 - 3%
Polymer (e.g. maleic/acrylic acid copolymer, 0 anchoring polymer such as, e.g., lauryl methacrylate/acrylic acid copolymer) 0 - 3%
Glycerol 3 - 8%
Enzymes (calculated as pure enzyme 0.0001 - 0.2%
protein) Minor ingredients (e.g. hydrotropes, dispersants, perfume, optical brighteners) 0 - 5%
5) Detergent formulations as described in 1 ) - 4) wherein all or part of the linear alkylbenzenesulfonate is replaced by (C12-C18) alkyl sulfate.
6) Detergent formulations as described in 1 ) - 5) which contain a stabilized or20 encapsulated peracid, either as an additional component or as a substitute for already specified bleach systems.
7) A detergent composition formulated as a non-aqueous detergent liquid comprising a liquid nonionic surfactant such as, e.g., linear alkoxylated primary alcohol, a builder system (e.g. phosphate), enzyme and alkali. The detergent may25 also comprise anionic surfactant and/or a bleach system.
Dishwashing and other multi-comPonent. enzvme-containing comPositions Examples of relevant types of formulations of this kind include the following:
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96/00005 1 ) LIQUID DISHWASHING COMPOSITION WITH CLEANING SURFACTANT
SYSTEM, COMPRISING:
- Nonionic surfactant O - 1.5%
Octadecyl dimethylamine N-oxide dihydrate 0 - 5%
80: 20 wt. C 1 8/C 1 6 blend of octadecyl dimethyiamine N-oxide dihydrate and hexadecyldimethyl amine N-oxide dihydrate 0 - 4%
70: 30 wt. C 1 8/C 1 6 blend of octadecyl bis (hydroxyethyl)amine N-oxide anhydrous and 0 hexadecyl bis 0 - 5%
(hydroxyethyl)amine N-oxide anhydrous C,3-C15 alkyl ethoxysulfate with an average degree of ethoxylation of 3 O - 10%
C12-C15 alkyl ethoxysulFate with an average degree of ethoxylation of 3 O - 5%
C~3. C~5 ethoxylated alcohol with an average degree of ethoxylation of 12 0 - 5%
A blend of C,2-C15 ethoxylated alcohols with an average degree of ethoxylation of 9 O - 6.5%
A blend of C13-C15 ethoxylated alcohols with an average degree of ethoxylation of 30 0 - 4%
Sodium disilicate 0 - 33%
Sodium tripolyphospha~e O - 46%
Sodium citrate O - 28%
Citric acid 0 - 29%
Sodium carbonate 0 - 20%
Sodium perborate monohydrate 0 - 11.5%
Tetraacetylethylenediamine (TAED) 0 - 4%
Maleic acid/acrylic acid copolymer 0 - 7.5%
Sodium sulphate 0 - 12.5%
Enzymes 0.0001 - 0.2%
CA 0220870~ 1997-06-2~
WO 9612 17 16 PCTIDK9~;/C _ _ 2) NON-AQUEOUS LIQUID AUTOMATIC DISHWASHING COMPOSITION
COMPRISING:
Liquid nonionic surfactant (e.g. alcohol ethoxylates) 2.0 - 10.0 %
Alkali metal silicate 3.0 - 1 5.0 %
Alkali metal phosphate 20.0 - 40.0%
Liquid carrier selected from higher glycols, polyglycols, polyoxides, glycolethers 25.0 - 45.0 %
Stabilizer (e.g. a partial ester of phosphoric 0 acid and a C16-C18 alkanol) 0.5 - 7.0%
Foam suppressor (e.g. silicone) 0 - 1.5 %
Enzymes 0.0001 - 0.2%
3) NON-AQUEOUS LIQUID DISHWASHING COMPOSITION COMPRISING:
Liquid nonionic surfactant (e.g. alcohol ethoxylates) 2.0 -1 0.0%
Sodium silicate 3.0 - 1 5 .0%
Alkali metal carbonate 7.0 - 20.0 %
Sodium citrate 0.0 - 1.5%
Stabilizing system (e.g. mixtures of finely divided silicone and low molecular weight dialkyl polyglycol ethers) 0.5 - 7.0%
Low molecule weight polyacrylate polymer 5.0 - 15.0%
Clay gel thickener (e.g. bentonite) 0.0 - 10.0%
Hydroxypropyl cellulose polymer 0.0 - 0.6%
Enzymes 0.0001 - 0.2%
Liquid carrier selected from higher Iycols, polyglycols, polyoxides and glycol ethers Balance CA 0220870~ 1997-06-2~
wo 96/21716 PCT/I)K96/00005 4) THIXOTROPIC LIQUID AUTOMATIC DISHWASHING COMPOSITION
~ COMPRISING:
- C12-C14 fatty acid O - 0.5%
Block co-polymer surfactant 1.5 - 15.0%
Sodium citrate O - 12%
Sodium tripolyphosphate O - 1 5 %
Sodium carbonate O - 8%
Aluminium tristearate O - 0.1%
Sodium cumene sulphonate O - 1 .7%
0 Polyacrylate thickener 1 .32 - 2.5%
Sodium polyacrylate 2.4 - 6.0%
Boric acid O - 4.0%
Sodium formate O - 0.45%
Calcium formate O - 0.2%
15 Sodium n-decydiphenyl oxide disulphonate O - 4.0%
Monoethanol amine (MEA) O - 1.86%
Sodium hydroxide (50%) 1.9 - 9.3%
1,2-Propanediol O - 9.4%
Enzymes 0. 0001 - O . 2 %
20 Suds suppressor, dye, perfumes, water Balance CA 0220870~ 1997-06-2S
W O96121716 PCTADh~6/00005 5) LIQUID AUTOMATIC DISHWASHING COMPOSITION COMPRISING:
Alcohol ethoxylate O - 20%
Fatty acid ester sulphonate 0 - 30%
Sodium dodecyl sulphate 0 - 20%
Alkyl polyglycoside 0 - 21%
Oleic acid 0 - 1 0%
Sodium disilicate monohydrate 1 8 - 33%
Sodium citrate dihydrate 18 - 33%
Sodium stearate O - 2.5%
Sodium perborate monohydrate 0 - 13%
Tetraacetylethylenediamine (TAED) 0 - 8%
Maleic acid/acrylic acid copolymer 4 - 8%
Enzymes 0.0001 - 0.2%
6) LIQUID AUTOMATIC DISHWASHING COMPOSITION CONTAINING
15 PROTECTED BLEACH PARTICLES, COMPRISING:
Sodium silicate 5 - 1 0%
Tetrapotassium pyrophosphate 1 5 - 25 %
Sodium triphosphate 0 - 2%
Potassium carbonate 4 - 8%
20 Protected bleach particles, e.g. chlorine 5 - 10%
Polymeric thickener 0.7 - 1.5%
Potassium hydroxide O - 2%
Enzymes 0.0001 - 0.2%
Water Balance CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K~G/'~,0-S5 7) Automatic dishwashing compositions as described in 1 ) and 5), wherein perborate is replaced by percarbonate.
Dishwashing and other multi-comPonent. enzvme-containing comPositions Examples of relevant types of formulations of this kind include the following:
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96/00005 1 ) LIQUID DISHWASHING COMPOSITION WITH CLEANING SURFACTANT
SYSTEM, COMPRISING:
- Nonionic surfactant O - 1.5%
Octadecyl dimethylamine N-oxide dihydrate 0 - 5%
80: 20 wt. C 1 8/C 1 6 blend of octadecyl dimethyiamine N-oxide dihydrate and hexadecyldimethyl amine N-oxide dihydrate 0 - 4%
70: 30 wt. C 1 8/C 1 6 blend of octadecyl bis (hydroxyethyl)amine N-oxide anhydrous and 0 hexadecyl bis 0 - 5%
(hydroxyethyl)amine N-oxide anhydrous C,3-C15 alkyl ethoxysulfate with an average degree of ethoxylation of 3 O - 10%
C12-C15 alkyl ethoxysulFate with an average degree of ethoxylation of 3 O - 5%
C~3. C~5 ethoxylated alcohol with an average degree of ethoxylation of 12 0 - 5%
A blend of C,2-C15 ethoxylated alcohols with an average degree of ethoxylation of 9 O - 6.5%
A blend of C13-C15 ethoxylated alcohols with an average degree of ethoxylation of 30 0 - 4%
Sodium disilicate 0 - 33%
Sodium tripolyphospha~e O - 46%
Sodium citrate O - 28%
Citric acid 0 - 29%
Sodium carbonate 0 - 20%
Sodium perborate monohydrate 0 - 11.5%
Tetraacetylethylenediamine (TAED) 0 - 4%
Maleic acid/acrylic acid copolymer 0 - 7.5%
Sodium sulphate 0 - 12.5%
Enzymes 0.0001 - 0.2%
CA 0220870~ 1997-06-2~
WO 9612 17 16 PCTIDK9~;/C _ _ 2) NON-AQUEOUS LIQUID AUTOMATIC DISHWASHING COMPOSITION
COMPRISING:
Liquid nonionic surfactant (e.g. alcohol ethoxylates) 2.0 - 10.0 %
Alkali metal silicate 3.0 - 1 5.0 %
Alkali metal phosphate 20.0 - 40.0%
Liquid carrier selected from higher glycols, polyglycols, polyoxides, glycolethers 25.0 - 45.0 %
Stabilizer (e.g. a partial ester of phosphoric 0 acid and a C16-C18 alkanol) 0.5 - 7.0%
Foam suppressor (e.g. silicone) 0 - 1.5 %
Enzymes 0.0001 - 0.2%
3) NON-AQUEOUS LIQUID DISHWASHING COMPOSITION COMPRISING:
Liquid nonionic surfactant (e.g. alcohol ethoxylates) 2.0 -1 0.0%
Sodium silicate 3.0 - 1 5 .0%
Alkali metal carbonate 7.0 - 20.0 %
Sodium citrate 0.0 - 1.5%
Stabilizing system (e.g. mixtures of finely divided silicone and low molecular weight dialkyl polyglycol ethers) 0.5 - 7.0%
Low molecule weight polyacrylate polymer 5.0 - 15.0%
Clay gel thickener (e.g. bentonite) 0.0 - 10.0%
Hydroxypropyl cellulose polymer 0.0 - 0.6%
Enzymes 0.0001 - 0.2%
Liquid carrier selected from higher Iycols, polyglycols, polyoxides and glycol ethers Balance CA 0220870~ 1997-06-2~
wo 96/21716 PCT/I)K96/00005 4) THIXOTROPIC LIQUID AUTOMATIC DISHWASHING COMPOSITION
~ COMPRISING:
- C12-C14 fatty acid O - 0.5%
Block co-polymer surfactant 1.5 - 15.0%
Sodium citrate O - 12%
Sodium tripolyphosphate O - 1 5 %
Sodium carbonate O - 8%
Aluminium tristearate O - 0.1%
Sodium cumene sulphonate O - 1 .7%
0 Polyacrylate thickener 1 .32 - 2.5%
Sodium polyacrylate 2.4 - 6.0%
Boric acid O - 4.0%
Sodium formate O - 0.45%
Calcium formate O - 0.2%
15 Sodium n-decydiphenyl oxide disulphonate O - 4.0%
Monoethanol amine (MEA) O - 1.86%
Sodium hydroxide (50%) 1.9 - 9.3%
1,2-Propanediol O - 9.4%
Enzymes 0. 0001 - O . 2 %
20 Suds suppressor, dye, perfumes, water Balance CA 0220870~ 1997-06-2S
W O96121716 PCTADh~6/00005 5) LIQUID AUTOMATIC DISHWASHING COMPOSITION COMPRISING:
Alcohol ethoxylate O - 20%
Fatty acid ester sulphonate 0 - 30%
Sodium dodecyl sulphate 0 - 20%
Alkyl polyglycoside 0 - 21%
Oleic acid 0 - 1 0%
Sodium disilicate monohydrate 1 8 - 33%
Sodium citrate dihydrate 18 - 33%
Sodium stearate O - 2.5%
Sodium perborate monohydrate 0 - 13%
Tetraacetylethylenediamine (TAED) 0 - 8%
Maleic acid/acrylic acid copolymer 4 - 8%
Enzymes 0.0001 - 0.2%
6) LIQUID AUTOMATIC DISHWASHING COMPOSITION CONTAINING
15 PROTECTED BLEACH PARTICLES, COMPRISING:
Sodium silicate 5 - 1 0%
Tetrapotassium pyrophosphate 1 5 - 25 %
Sodium triphosphate 0 - 2%
Potassium carbonate 4 - 8%
20 Protected bleach particles, e.g. chlorine 5 - 10%
Polymeric thickener 0.7 - 1.5%
Potassium hydroxide O - 2%
Enzymes 0.0001 - 0.2%
Water Balance CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K~G/'~,0-S5 7) Automatic dishwashing compositions as described in 1 ) and 5), wherein perborate is replaced by percarbonate.
8) Automatic dishwashing compositions as described in 1), which additionally contain a manganese catalyst. The manganese catalyst may, e.g., be one of the 5 compounds described in "Efficient manganese catalysts for low-temperature bleaching", Nature 369, 1994, pp. 637-639.
The "enzymes" content of the above formulations may include the content of enzyme inhibitor(s) pre!sent. Where appropriate, a particular formulation encompassed within one of the types recited above may contain an organic 0 solvent of a type which i~s not specifically mentioned above in connection with that type of formulation, but which has functioned, e.g., as a solubilizing solvent for an inhibitor present in a liquid enzyme/inhibitor composition of the invention which has been incorporated in the particular formulation in question.
A liquid enzyme/inhibitor composition of the invention of the invention may be 15 incorporated in a detergent composition so as to give an enzyme concentrationwhich is conventionally employed in detergents. It is at present contemplated that, for a detergent cornposition of the invention, a liquid enzyme/inhibitor composition of the invention may, e.g., be incorporated in an amount which - fora given enzyme present in the enzyme/inhibitor composition - corresponds to an 20 amount of enzyme in the range 0.00001-1 mg (calculated as pure enzyme protein) of enzyme per liter of wash liquor.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK9~'..~~~,5 Tests of Stabilizers The inhibitory effectiveness of an inhibitor may be tested in various ways, illustrated here by the following two tests for the case of a protease/protease inhibitor:
5 a) Storaqe Stability Test in Liquid Detergent: Liquid enzyme/inhibitor composition is added to a liquid detergent formulation which is stored under well-defined conditions. The enzyme activity of each enzyme is determined as a function of time (e.g. after 1, 3, and 7 days).
To calculate the inhibition efficiency from the storage stability data, a reaction 10 mechanism is proposed. The following reactions give a relatively simple, yet plausible, mechanism for a liquid detergent containing protease (P), lipase (L), and inhibitor (I):
I) Autodigestion of protease:
P + P~ Dp + P
15 Il) Denaturation of protease:
P ~ Dp lll) Inhibition of protease:
P + I ~ Pl IV) Protease digestion of inhibited enzyme:
P + Pl ~ P + Dp + I
V) Denaturation of inhibited enzyme:
Pl ~ Dp + I
Vl) Protease digestion of lipase:
CA 0220870~ 1997-06-2~
Wo 96/21716 PCT/DK96/00005 P + L~ P + D, Vll) Denaturation of lipase:
L- D, where Dp and D, are denatured (i.e. non-active) protease and lipase.
5 From these reactions three coupled differential equations are derived describing the deactivation of P, L and Pl. The reaction rate constants are derived from storage stability data by the use of a parameter estimation method (Gauss-Newton with the Levenberg modification). The storage stability data give the concentration of (P+ Pl) and L as a function of time.
10 Reaction lll is much faster than the other reactions and equilibrium is assumed in the calculations. Reaction IV is excluded from the system to reduce the number of parameters thereby describing the stability of the inhibited enzyme by only one reaction rate constant (from equation V).
When a large surplus of inhibitor molecules (relative to protease molecules) is 5 present, the concentration of inhibitor may be assumed, as a reasonable approximation, to be constant.
The specific values of the reaction rate constants are somewhat sensitive to small variations in the ciata, but the sensitivity is reduced significantly by giving the results relative to the value for boric acid. The use of boric acid [as well as 20 closely related or equivalent substances such as alkali metal borates (e.g. borax) and boric oxide] for the purpose of inhibiting, in particular, proteases is wellknown (see, e.g., EP 0 451 924 A2), but the low inhibitory strength in combination with the generally rather poor solubility of such substances (which is further illustrated for boric acid in the working examples herein; vide infra) 25 renders them generally unsuitable for use in the context of the present invention [in which the inhibitor(s~ and/or amount(s) thereof present in a liquid composition =- ~
CA 0220870~ 1997-06-25 W O96/21716 PCT~DX~G~ CD~
of the invention should be such as to still give rise to good enzyme stabilization when the liquid composition is incorporated as a component of a multi-component composition]. Thus, compounds such as boric acid, alkali metal borates (e.g. borax) and boric oxide will generally be excluded as inhibitors in the 5 context of the present invention.
An "improvement factor" may be defined as follows:
Ki (boric acid) IFj =
Ki ( inhibitor) 10 IFj defined in this manner thus provides a measure of the inhibition efficiency of a given inhibitor relative to boric acid.
b) Determination of Kj: The inhibition constant Kj may be determined by using standard methods; for reference see Keller et al, Biochem. Biophys. Res. Comm.
176, 1991, pp.401-405; J. Bieth in Baver-Sym~osium "Proteinase Inhibitors", 15 pp. 463-469, Springer-Verlag, 1974, and Lone Kierstein Hansen in "Deter-mination of Soecific Activities of Selected Detergent Proteases usin~ Protease Activitv. Molecular Weights, Kinetic Parameters and Inhibition Kinetics", PhD
thesis, Novo Nordisk A/S and University of Copenhagen, 1991. The determination may, if desired, be performed in the presence of non-enzyme 20 components (surfactant(s), etc.) of a detergent composition.
Conditions appropriate for determining Kj values for inhibition of enzymes will typically be achieved by employing a buffer system which provides a suitable pH
and which does not react or form complexes with the enzyme(s) or inhibitor(s) in question. A suitable buffer system for many enzyme/inhibitor interactions will, 25 for example, be a glycyl-glycine buffer at a mildly alkaline pH, e.g. pH 8.6, and at ambient temperature (typically 25~C).
CA 0220870~ 1997-06-2~
Exr~erimental section The invention is further illustrated and substantiated in the following examples, which are not intended to be in any way limiting to the scope of the invention as claimed .
The following procedures are illustrative of suitable approaches to the synthesis of numerous types of boronic and borinic acids:
PreParation of thio~hene-3-boronic acid: 3-Bromothiophene (0.043 m) in sodium dried ether (100 ml) was cooled to -60~C. Butyllithium (30 ml of 1 M) was added 10 rapidly. The mixture was ~hen stirred for 3 minutes, thereafter tri-n-butyl borate (0.043 m) or trimethylborate (0.043 m) in sodium dried ether (25 ml) was added.
The mixture was stirred for 4 hours and allowed to warm to room temperature.
Thereafter the reaction mixture was treated with hydrochloric acid (1 M) and theether layer was separated. The aqueous layer was extracted with ether (2 times 15 25 ml). The combined ether layers were extracted with sodium hydroxide (1 M).The alkaline solution was then acidified with hydrochloric acid (10%), thus pre-cipitating the desired boronic acid. The boronic acid was isolated and then recrystallized from water//3thanol and allowed to dry in air.
C4H5B02S, mpt. 163-164"C.
20 Preparation of diphenvlborinic acid: This was prepared using the above method.
The Grignard reagent was prepared from bromobenzene and Magnesium turnings.
However, two moles of Grignard reagent were used per one mole of tri-n-butylborate. The borinic acid so formed was isolated by reaction with ethanolamine thus yielding the diphenylborinic acid, ethanolamine complex 25 ((C6H5)2BO.CH2CH2NH2), which is easierto handle. Mpt.192-194~C.
CA 02208705 1997-06-2~
W O96/21716 PCT~DK96/00005 Preparation of 4-formvlphenvl-boronic acid: This compound may be prepared as described in Chem. Ber. 123 (1990), pp. 1841-1843. 4-Bromobenzaldehyde diethylacetal is reacted with magnesium turnings in tetrahydrofuran, after whichtributyl borate dissolved in ether is added and the mixture is worked up with 5 sulfuric acid.
Determination of K;
Inhibition constants, Kj, for the inhibition of the protease SavinaselM were determined using standard methods under the following conditions:
10 Substrate: Succinyl-Alanine-Alanine-Proline-Phenylalanine-para-nitro-anilide =
SAAPFpNA (from Sigma, catalogue No. S-7388).
Buffer: 0.1 M Glycyl-glycine pH 8.6; 1.5 ml 15% Brij~ 35 per litre; 25~C (glycyl-glycine from Sigma, catalogue No. G-3028).
Enzvme concentration in assay:
15 Savinase~: 1 x1 o-lo - 3X1 o-lo M
The initial rate of substrate hydrolysis was determined at nine substrate concentrations in the range of 0.01 to 2 mM using a Cobas Fara automated spectrophotometer. The kinetic parameters Vmax and Km were determined using ENZFITTER (a non-linear regression data analysis program). kCat was calculated 20 from the equation Vm~X = kCat x [Eo]~ The concentration of active enzyme [Eo] was determined by active site titration using very strongly binding protein-type protease inhibitors. Inhibition constants Kj were calculated from plots of Km/kCat as a function of the concentration of inhibitor. The inhibitors were assumed to be 100% pure, and the molar concentrations were determined from weighed 25 amounts and molecular weights.
CA 0220870~ 1997-06-2~
Wo 96121716 PcT~ 1Gloooos The resulting values of the inhibition constants K; for a series of boronic acidenzyme stabilizers (inhibitors) tested are listed below, together with values of the ratio [I]t/K; for some of these inhibitors.
Table 1.
5 Inhibition constants and ~llt/Kj values for the inhibition of SavinaseTM bv different boronic acid derivatives. Boric acid is included for comparison Inhibitor 103 x Kj [I]t/K;
(K; in mol/l) 2% 1.5%
Boric Acid 1 0 Phenyl-boronic acid 0.1 1 1490 0 3-Acetamidophenyl-boronic acid 0.09 1240 930 Benzofuran-2-boronic acid 0.03 4115 4-Formylphenyl-boronic acid 0.03 4445 3335 Thiophene-2-boronic acid 0.14 Thiophene-3-boronic acid 0.17 Naphthalene-1-boronic acid 0.13 2-Formylphenyl-boronic acid 0 . 2 3-Formylphenyl-boronic acid 0.07 % w/w of inhibitor in solution.
CA 0220870~ 1997-06-2~
WO 96/21716 PCTIDK~ ~5 Storaae stability tests in liauid detergent In the following, reference is made to KNPU ("Kilo Novo Protease Units" in relation to the SavinaseW preparations, and to KLU ("Kilo Lipase Units") in relation 5 to LipolaseTM preparations. One KNPU corresponds to 2.53 mg (ca. 9.4-10-5 mmol) of pure enzyme protein. Reference may be made to a pamphlet, AF 220/1-GB (available on request from Novo Nordisk A/S, Bagsvaerd, Denmark), concerning determination of SavinaseW activity.
One Lipase Unit (LU) is defined as the amount of enzyme which, under standard 10 conditions (30.0~C, pH 7.0; with Gum Arabic as emulsifier and tributyrin as substrate) liberates 1 ~mol of titrable butyric acid per minute. A pamphlet (AF
95/5) describing this analytical method in more detail is available upon requestfrom Novo Nordisk A/S, Bagsvaerd, Denmark. One KLU corresponds to 0.2 mg (ca. 6.7 ~ 1 o-6 mmol) of pure enzyme protein.
5 Various protease inhibitors were tested in storage stability (enzyme activity retention) tests in liquid detergent, using the method described above, under conditions as summarized below. A 4 ~/O w/w solution of each inhibitor (except boric acid) in mono-propylene glycol (MPG) was prepared~ Boric acid is poorly soluble in the medium in ques~ion, and was therefore dissolved in the final 20 detergent formulation (to give a boric acid concentration of 1% w/w therein) rather than in the liquid enzyme/inhibitor composition.
First test series: For the first test series, equal parts by weight of inhibitorsolution and of SavinaseW 16.0 L, Type EX (liquid protease preparation containing 16 KNPU of protease per gram; Novo Nordisk A/S, Bagsvaerd, Denmark) were 25 mixed, giving Savinase~ 8 L EX preparations each containing 2% w/w of inhibitor. The storage stability results for detergent compositions each containing 1% w/w of such a Savinase~/inhibitor preparation, 98% w/w of "detergent base _ _ CA 0220870~ 1997-06-2~
wo 96r21716 PCT/I)~96/OOOOS
I" (videinfra) and 1 % w/w of LipolaseTM 100 L, Type EX (liquid lipase preparation containing 100 KLU of lipase per gram; Novo Nordisk A/S, Bagsvaerd, Denmark) were as follows:
% Residual LipolaserU activities ~storage at 30~C):
Inhibitor Period of storage (days) 10 None 34 6 0 1% Boric acid 82 52 21 Phenyl-boronic acid 79 46 17 Benzofuran-2-boronic acid 83 54 24 4-Formylphenyl-boronic acid 86 64 41 No Savinase~ or inhibitor 88 72 55 % Residual SavinaseTM acltivities (7 days storage at 30~C):
Inhibitor % Activity None 1 0 1% Boric acid 74 Phenyl-boronic acid 67 Benzofuran-2-boronic acid 76 25 4-Formylphenyl-boronic acid 85 The above results demonstrate, infer alia, that the retention of LipolaselM and Savinase~ activities in the detergent composition is significantly improved by the presence of the inhibitors.
CA 0220870~ 1997-06-2~
Second test series: For the second test series, Savinase~ 16.0 L EX, 4% w/w inhibitor in MP~i, and pure MPG were mixed in a weight ratio of 50:37.5:12.5, respectively, giving SavinaselM 8 L EX preparations each containing 1.5% w/w of inhibitor. The storage stability results for detergent compositions each 5 containing 1% w/w of such a SavinaseW/inhibitor preparation, 98% w/w of "detergent base ll" (vide infra) and 1 % w/w of Lipolase~ 100 L, Type EX were as follows:
% Residual LipolaserM activities (storage at 30~C):
10 Inhibitor Period of storage (days) None 53 8 0 15 4-Formylphenyl-boronicacid 58 41 28 3-Acetamidophenyl-boronic acid 24 9 5 No Savinase~ or inhibitor 76 67 55 Third test series: SavinaselM 8 L EX preparations each containing 1.5% w/w of 20 inhibitor were prepared in the same manner as for the second test series, above.
The storage stability results for detergent compositions each containing 1% w/w of such a SavinaseTM/inhibitor preparation, 98% w/w of "inactivated" OMO~
Micro (vide infra) and 1% w/w of LipolaseTM 100 L, Type EX were as follows:
CA 0220870~ 1997-06-2~
WO 96/21716 PCTlDK9~ 5 % Residual Lipolase~ activities (storage at 35~C):
Inhibitor Period of storage (days) None 90 88 85 4-Formylphenyl-boronic acid 98 99 99 No SavinaselM or inhibitor 99 99 99 Fourth test series: Essentially as for the third series, above, with the exceptions that a storage temperature of 30~C was employed, and inactivated OMOTM micro was replaced with "detergent base lll" (vide jnfra).
~/0 Residual Lipolase~ acl:ivities (storage at 30~C):
Inhibitor Period of storage (days) 20 None 45 19 4-Formylphenyl-boronic acid 32 20 17 No Savinase~ or inhibitor 39 28 24 The latter results demonstrate, inter alia, that the retention of Lipolase~ activity 25 in the various detergent compositions is significantly improved by the presence of the inhibitors.
WO 96/21716 PCT/I)K96/00005 Composition of deterqent base I (US tvpe):
Component % w/w (as pure components) Nansa~ 1 1 69/p 1 0. 3 (Linear Alkylbenzene Sulfonate, LAS) BerollM 452 3.5 (Alkyl Ether Sulfate, AES) Oleic acid 0.5 Coconut fatty acid 0.5 Dobanol'M 25-7 6.4 (Alcohol Ethoxylate, AEO) 0 Sodium xylenesulfonate 5.1 Ethanol 0.7 MPG 2.7 Glycerol 0.5 Sodium sulfate 0.4 15 Sodium carbonate 2.7 Sodium citrate 4.4 Citric acid 1.5 Water to balance WO 96/21716 PCTIDK~)G~ 5 Composition of deters~ent base il:
Component % w/w Nansa~ 1169/p 10.30 SulfatollM NA/25 1.40 Oleic acid 7.05 Coconut fatty acid 7.05 DobanolTM 25-7 13.10 0 Triethanolamine 5.50 NaOH, 40% 2.00 Sodium xylenesulfonate 1.00 Ethanol 4.90 MPG 2.70 5 Sodium sulfate 0.20 Sodium citrate 1.40 Dequest~ 2060 S 0.40 Water to balance CA 0220870~ 1997-06-25 Composition of detergent base lll:
Component % w/w Nansa'M 11 69/p 7.00 Oleic Acid 0.45 Coconut fa~ty acid 0.45 LutensollM AO4 3.80 MPG 0.50 0 Glycerol 4.60 Na5P3010 H20 22.60 Na2SiO3 5H2O 1.70 Sodium carbonate 1.43 Water to balance 15 OMOlM Micro was a retail product purchased in a Danish supermarket. The enzyme content therein was inactivated by treatment in a microwave oven (85~C, 5 minutes).
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96~0000S
Examples of liquid enzyme/inhibitor compositions Some examples of iiquid enzymelinhibitor compositions according to the invention are as follows (all compositions were solutions of acceptable 5 appearance):
1) 0.1 9 4-bromophenyl boronic acid + 10 g Savinase 16.0 L, Type EX: this composition has a molar inhibitor:enzyme (I:E) ratio of about 33.
2) 0.29 3,5-dichlorophenyl boronic acid + 40 9 Savinase 16.0 L, Type EX: this composition has a molar l:E ratio of about 17.
0 3) 0.1 9 5-chlorothiophene-2-boronicacid + 10 9 Savinase 16.0 L, Type EX: this composition has a molar l:E ratio of about 40.
4) 0.1 9 phenyl boronic acid + 10 9 Savinase 16.0 L, Type EX: this composition has a molar l:E ratio of about 54.
5) 0.2 9 phenyl boronic acid + 10 9 Savinase 16.0 L, Type EX: this composition 15 has a molar l:E ratio of about 108.
The "enzymes" content of the above formulations may include the content of enzyme inhibitor(s) pre!sent. Where appropriate, a particular formulation encompassed within one of the types recited above may contain an organic 0 solvent of a type which i~s not specifically mentioned above in connection with that type of formulation, but which has functioned, e.g., as a solubilizing solvent for an inhibitor present in a liquid enzyme/inhibitor composition of the invention which has been incorporated in the particular formulation in question.
A liquid enzyme/inhibitor composition of the invention of the invention may be 15 incorporated in a detergent composition so as to give an enzyme concentrationwhich is conventionally employed in detergents. It is at present contemplated that, for a detergent cornposition of the invention, a liquid enzyme/inhibitor composition of the invention may, e.g., be incorporated in an amount which - fora given enzyme present in the enzyme/inhibitor composition - corresponds to an 20 amount of enzyme in the range 0.00001-1 mg (calculated as pure enzyme protein) of enzyme per liter of wash liquor.
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/DK9~'..~~~,5 Tests of Stabilizers The inhibitory effectiveness of an inhibitor may be tested in various ways, illustrated here by the following two tests for the case of a protease/protease inhibitor:
5 a) Storaqe Stability Test in Liquid Detergent: Liquid enzyme/inhibitor composition is added to a liquid detergent formulation which is stored under well-defined conditions. The enzyme activity of each enzyme is determined as a function of time (e.g. after 1, 3, and 7 days).
To calculate the inhibition efficiency from the storage stability data, a reaction 10 mechanism is proposed. The following reactions give a relatively simple, yet plausible, mechanism for a liquid detergent containing protease (P), lipase (L), and inhibitor (I):
I) Autodigestion of protease:
P + P~ Dp + P
15 Il) Denaturation of protease:
P ~ Dp lll) Inhibition of protease:
P + I ~ Pl IV) Protease digestion of inhibited enzyme:
P + Pl ~ P + Dp + I
V) Denaturation of inhibited enzyme:
Pl ~ Dp + I
Vl) Protease digestion of lipase:
CA 0220870~ 1997-06-2~
Wo 96/21716 PCT/DK96/00005 P + L~ P + D, Vll) Denaturation of lipase:
L- D, where Dp and D, are denatured (i.e. non-active) protease and lipase.
5 From these reactions three coupled differential equations are derived describing the deactivation of P, L and Pl. The reaction rate constants are derived from storage stability data by the use of a parameter estimation method (Gauss-Newton with the Levenberg modification). The storage stability data give the concentration of (P+ Pl) and L as a function of time.
10 Reaction lll is much faster than the other reactions and equilibrium is assumed in the calculations. Reaction IV is excluded from the system to reduce the number of parameters thereby describing the stability of the inhibited enzyme by only one reaction rate constant (from equation V).
When a large surplus of inhibitor molecules (relative to protease molecules) is 5 present, the concentration of inhibitor may be assumed, as a reasonable approximation, to be constant.
The specific values of the reaction rate constants are somewhat sensitive to small variations in the ciata, but the sensitivity is reduced significantly by giving the results relative to the value for boric acid. The use of boric acid [as well as 20 closely related or equivalent substances such as alkali metal borates (e.g. borax) and boric oxide] for the purpose of inhibiting, in particular, proteases is wellknown (see, e.g., EP 0 451 924 A2), but the low inhibitory strength in combination with the generally rather poor solubility of such substances (which is further illustrated for boric acid in the working examples herein; vide infra) 25 renders them generally unsuitable for use in the context of the present invention [in which the inhibitor(s~ and/or amount(s) thereof present in a liquid composition =- ~
CA 0220870~ 1997-06-25 W O96/21716 PCT~DX~G~ CD~
of the invention should be such as to still give rise to good enzyme stabilization when the liquid composition is incorporated as a component of a multi-component composition]. Thus, compounds such as boric acid, alkali metal borates (e.g. borax) and boric oxide will generally be excluded as inhibitors in the 5 context of the present invention.
An "improvement factor" may be defined as follows:
Ki (boric acid) IFj =
Ki ( inhibitor) 10 IFj defined in this manner thus provides a measure of the inhibition efficiency of a given inhibitor relative to boric acid.
b) Determination of Kj: The inhibition constant Kj may be determined by using standard methods; for reference see Keller et al, Biochem. Biophys. Res. Comm.
176, 1991, pp.401-405; J. Bieth in Baver-Sym~osium "Proteinase Inhibitors", 15 pp. 463-469, Springer-Verlag, 1974, and Lone Kierstein Hansen in "Deter-mination of Soecific Activities of Selected Detergent Proteases usin~ Protease Activitv. Molecular Weights, Kinetic Parameters and Inhibition Kinetics", PhD
thesis, Novo Nordisk A/S and University of Copenhagen, 1991. The determination may, if desired, be performed in the presence of non-enzyme 20 components (surfactant(s), etc.) of a detergent composition.
Conditions appropriate for determining Kj values for inhibition of enzymes will typically be achieved by employing a buffer system which provides a suitable pH
and which does not react or form complexes with the enzyme(s) or inhibitor(s) in question. A suitable buffer system for many enzyme/inhibitor interactions will, 25 for example, be a glycyl-glycine buffer at a mildly alkaline pH, e.g. pH 8.6, and at ambient temperature (typically 25~C).
CA 0220870~ 1997-06-2~
Exr~erimental section The invention is further illustrated and substantiated in the following examples, which are not intended to be in any way limiting to the scope of the invention as claimed .
The following procedures are illustrative of suitable approaches to the synthesis of numerous types of boronic and borinic acids:
PreParation of thio~hene-3-boronic acid: 3-Bromothiophene (0.043 m) in sodium dried ether (100 ml) was cooled to -60~C. Butyllithium (30 ml of 1 M) was added 10 rapidly. The mixture was ~hen stirred for 3 minutes, thereafter tri-n-butyl borate (0.043 m) or trimethylborate (0.043 m) in sodium dried ether (25 ml) was added.
The mixture was stirred for 4 hours and allowed to warm to room temperature.
Thereafter the reaction mixture was treated with hydrochloric acid (1 M) and theether layer was separated. The aqueous layer was extracted with ether (2 times 15 25 ml). The combined ether layers were extracted with sodium hydroxide (1 M).The alkaline solution was then acidified with hydrochloric acid (10%), thus pre-cipitating the desired boronic acid. The boronic acid was isolated and then recrystallized from water//3thanol and allowed to dry in air.
C4H5B02S, mpt. 163-164"C.
20 Preparation of diphenvlborinic acid: This was prepared using the above method.
The Grignard reagent was prepared from bromobenzene and Magnesium turnings.
However, two moles of Grignard reagent were used per one mole of tri-n-butylborate. The borinic acid so formed was isolated by reaction with ethanolamine thus yielding the diphenylborinic acid, ethanolamine complex 25 ((C6H5)2BO.CH2CH2NH2), which is easierto handle. Mpt.192-194~C.
CA 02208705 1997-06-2~
W O96/21716 PCT~DK96/00005 Preparation of 4-formvlphenvl-boronic acid: This compound may be prepared as described in Chem. Ber. 123 (1990), pp. 1841-1843. 4-Bromobenzaldehyde diethylacetal is reacted with magnesium turnings in tetrahydrofuran, after whichtributyl borate dissolved in ether is added and the mixture is worked up with 5 sulfuric acid.
Determination of K;
Inhibition constants, Kj, for the inhibition of the protease SavinaselM were determined using standard methods under the following conditions:
10 Substrate: Succinyl-Alanine-Alanine-Proline-Phenylalanine-para-nitro-anilide =
SAAPFpNA (from Sigma, catalogue No. S-7388).
Buffer: 0.1 M Glycyl-glycine pH 8.6; 1.5 ml 15% Brij~ 35 per litre; 25~C (glycyl-glycine from Sigma, catalogue No. G-3028).
Enzvme concentration in assay:
15 Savinase~: 1 x1 o-lo - 3X1 o-lo M
The initial rate of substrate hydrolysis was determined at nine substrate concentrations in the range of 0.01 to 2 mM using a Cobas Fara automated spectrophotometer. The kinetic parameters Vmax and Km were determined using ENZFITTER (a non-linear regression data analysis program). kCat was calculated 20 from the equation Vm~X = kCat x [Eo]~ The concentration of active enzyme [Eo] was determined by active site titration using very strongly binding protein-type protease inhibitors. Inhibition constants Kj were calculated from plots of Km/kCat as a function of the concentration of inhibitor. The inhibitors were assumed to be 100% pure, and the molar concentrations were determined from weighed 25 amounts and molecular weights.
CA 0220870~ 1997-06-2~
Wo 96121716 PcT~ 1Gloooos The resulting values of the inhibition constants K; for a series of boronic acidenzyme stabilizers (inhibitors) tested are listed below, together with values of the ratio [I]t/K; for some of these inhibitors.
Table 1.
5 Inhibition constants and ~llt/Kj values for the inhibition of SavinaseTM bv different boronic acid derivatives. Boric acid is included for comparison Inhibitor 103 x Kj [I]t/K;
(K; in mol/l) 2% 1.5%
Boric Acid 1 0 Phenyl-boronic acid 0.1 1 1490 0 3-Acetamidophenyl-boronic acid 0.09 1240 930 Benzofuran-2-boronic acid 0.03 4115 4-Formylphenyl-boronic acid 0.03 4445 3335 Thiophene-2-boronic acid 0.14 Thiophene-3-boronic acid 0.17 Naphthalene-1-boronic acid 0.13 2-Formylphenyl-boronic acid 0 . 2 3-Formylphenyl-boronic acid 0.07 % w/w of inhibitor in solution.
CA 0220870~ 1997-06-2~
WO 96/21716 PCTIDK~ ~5 Storaae stability tests in liauid detergent In the following, reference is made to KNPU ("Kilo Novo Protease Units" in relation to the SavinaseW preparations, and to KLU ("Kilo Lipase Units") in relation 5 to LipolaseTM preparations. One KNPU corresponds to 2.53 mg (ca. 9.4-10-5 mmol) of pure enzyme protein. Reference may be made to a pamphlet, AF 220/1-GB (available on request from Novo Nordisk A/S, Bagsvaerd, Denmark), concerning determination of SavinaseW activity.
One Lipase Unit (LU) is defined as the amount of enzyme which, under standard 10 conditions (30.0~C, pH 7.0; with Gum Arabic as emulsifier and tributyrin as substrate) liberates 1 ~mol of titrable butyric acid per minute. A pamphlet (AF
95/5) describing this analytical method in more detail is available upon requestfrom Novo Nordisk A/S, Bagsvaerd, Denmark. One KLU corresponds to 0.2 mg (ca. 6.7 ~ 1 o-6 mmol) of pure enzyme protein.
5 Various protease inhibitors were tested in storage stability (enzyme activity retention) tests in liquid detergent, using the method described above, under conditions as summarized below. A 4 ~/O w/w solution of each inhibitor (except boric acid) in mono-propylene glycol (MPG) was prepared~ Boric acid is poorly soluble in the medium in ques~ion, and was therefore dissolved in the final 20 detergent formulation (to give a boric acid concentration of 1% w/w therein) rather than in the liquid enzyme/inhibitor composition.
First test series: For the first test series, equal parts by weight of inhibitorsolution and of SavinaseW 16.0 L, Type EX (liquid protease preparation containing 16 KNPU of protease per gram; Novo Nordisk A/S, Bagsvaerd, Denmark) were 25 mixed, giving Savinase~ 8 L EX preparations each containing 2% w/w of inhibitor. The storage stability results for detergent compositions each containing 1% w/w of such a Savinase~/inhibitor preparation, 98% w/w of "detergent base _ _ CA 0220870~ 1997-06-2~
wo 96r21716 PCT/I)~96/OOOOS
I" (videinfra) and 1 % w/w of LipolaseTM 100 L, Type EX (liquid lipase preparation containing 100 KLU of lipase per gram; Novo Nordisk A/S, Bagsvaerd, Denmark) were as follows:
% Residual LipolaserU activities ~storage at 30~C):
Inhibitor Period of storage (days) 10 None 34 6 0 1% Boric acid 82 52 21 Phenyl-boronic acid 79 46 17 Benzofuran-2-boronic acid 83 54 24 4-Formylphenyl-boronic acid 86 64 41 No Savinase~ or inhibitor 88 72 55 % Residual SavinaseTM acltivities (7 days storage at 30~C):
Inhibitor % Activity None 1 0 1% Boric acid 74 Phenyl-boronic acid 67 Benzofuran-2-boronic acid 76 25 4-Formylphenyl-boronic acid 85 The above results demonstrate, infer alia, that the retention of LipolaselM and Savinase~ activities in the detergent composition is significantly improved by the presence of the inhibitors.
CA 0220870~ 1997-06-2~
Second test series: For the second test series, Savinase~ 16.0 L EX, 4% w/w inhibitor in MP~i, and pure MPG were mixed in a weight ratio of 50:37.5:12.5, respectively, giving SavinaselM 8 L EX preparations each containing 1.5% w/w of inhibitor. The storage stability results for detergent compositions each 5 containing 1% w/w of such a SavinaseW/inhibitor preparation, 98% w/w of "detergent base ll" (vide infra) and 1 % w/w of Lipolase~ 100 L, Type EX were as follows:
% Residual LipolaserM activities (storage at 30~C):
10 Inhibitor Period of storage (days) None 53 8 0 15 4-Formylphenyl-boronicacid 58 41 28 3-Acetamidophenyl-boronic acid 24 9 5 No Savinase~ or inhibitor 76 67 55 Third test series: SavinaselM 8 L EX preparations each containing 1.5% w/w of 20 inhibitor were prepared in the same manner as for the second test series, above.
The storage stability results for detergent compositions each containing 1% w/w of such a SavinaseTM/inhibitor preparation, 98% w/w of "inactivated" OMO~
Micro (vide infra) and 1% w/w of LipolaseTM 100 L, Type EX were as follows:
CA 0220870~ 1997-06-2~
WO 96/21716 PCTlDK9~ 5 % Residual Lipolase~ activities (storage at 35~C):
Inhibitor Period of storage (days) None 90 88 85 4-Formylphenyl-boronic acid 98 99 99 No SavinaselM or inhibitor 99 99 99 Fourth test series: Essentially as for the third series, above, with the exceptions that a storage temperature of 30~C was employed, and inactivated OMOTM micro was replaced with "detergent base lll" (vide jnfra).
~/0 Residual Lipolase~ acl:ivities (storage at 30~C):
Inhibitor Period of storage (days) 20 None 45 19 4-Formylphenyl-boronic acid 32 20 17 No Savinase~ or inhibitor 39 28 24 The latter results demonstrate, inter alia, that the retention of Lipolase~ activity 25 in the various detergent compositions is significantly improved by the presence of the inhibitors.
WO 96/21716 PCT/I)K96/00005 Composition of deterqent base I (US tvpe):
Component % w/w (as pure components) Nansa~ 1 1 69/p 1 0. 3 (Linear Alkylbenzene Sulfonate, LAS) BerollM 452 3.5 (Alkyl Ether Sulfate, AES) Oleic acid 0.5 Coconut fatty acid 0.5 Dobanol'M 25-7 6.4 (Alcohol Ethoxylate, AEO) 0 Sodium xylenesulfonate 5.1 Ethanol 0.7 MPG 2.7 Glycerol 0.5 Sodium sulfate 0.4 15 Sodium carbonate 2.7 Sodium citrate 4.4 Citric acid 1.5 Water to balance WO 96/21716 PCTIDK~)G~ 5 Composition of deters~ent base il:
Component % w/w Nansa~ 1169/p 10.30 SulfatollM NA/25 1.40 Oleic acid 7.05 Coconut fatty acid 7.05 DobanolTM 25-7 13.10 0 Triethanolamine 5.50 NaOH, 40% 2.00 Sodium xylenesulfonate 1.00 Ethanol 4.90 MPG 2.70 5 Sodium sulfate 0.20 Sodium citrate 1.40 Dequest~ 2060 S 0.40 Water to balance CA 0220870~ 1997-06-25 Composition of detergent base lll:
Component % w/w Nansa'M 11 69/p 7.00 Oleic Acid 0.45 Coconut fa~ty acid 0.45 LutensollM AO4 3.80 MPG 0.50 0 Glycerol 4.60 Na5P3010 H20 22.60 Na2SiO3 5H2O 1.70 Sodium carbonate 1.43 Water to balance 15 OMOlM Micro was a retail product purchased in a Danish supermarket. The enzyme content therein was inactivated by treatment in a microwave oven (85~C, 5 minutes).
CA 0220870~ 1997-06-2~
WO 96/21716 PCT/I)K96~0000S
Examples of liquid enzyme/inhibitor compositions Some examples of iiquid enzymelinhibitor compositions according to the invention are as follows (all compositions were solutions of acceptable 5 appearance):
1) 0.1 9 4-bromophenyl boronic acid + 10 g Savinase 16.0 L, Type EX: this composition has a molar inhibitor:enzyme (I:E) ratio of about 33.
2) 0.29 3,5-dichlorophenyl boronic acid + 40 9 Savinase 16.0 L, Type EX: this composition has a molar l:E ratio of about 17.
0 3) 0.1 9 5-chlorothiophene-2-boronicacid + 10 9 Savinase 16.0 L, Type EX: this composition has a molar l:E ratio of about 40.
4) 0.1 9 phenyl boronic acid + 10 9 Savinase 16.0 L, Type EX: this composition has a molar l:E ratio of about 54.
5) 0.2 9 phenyl boronic acid + 10 9 Savinase 16.0 L, Type EX: this composition 15 has a molar l:E ratio of about 108.
Claims (13)
1. A liquid composition comprising:
(i) an enzyme in an amount exceeding 40 µM; and (ii) a reversible inhibitor of said enzyme in an amount effective to enhance thestorage stability of said enzyme in a multi-component composition into which said liquid composition is subsequently incorporated.
(i) an enzyme in an amount exceeding 40 µM; and (ii) a reversible inhibitor of said enzyme in an amount effective to enhance thestorage stability of said enzyme in a multi-component composition into which said liquid composition is subsequently incorporated.
2. A composition according to claim 1, wherein said enzyme is present in an amount of from 500 µM to 5 mM.
3. A composition according to claim 1 or 2, wherein the molar ratio of said inhibitor to said enzyme is at least 5.
4. A composition according to any one of claims 1-3, wherein the ratio [I]t/K i (as defined herein) is at least 50.
5. A composition according to claim 4, wherein the ratio [I]t/K i is the range of 250-5000.
6. A composition according to any one of the preceding claims, wherein said enzyme is selected from the group consisting of proteases, amylases, cellulases,lipases and oxidoreductases.
7. A composition according to any one of the preceding claims, wherein said enzyme is a protease.
8. A composition according to claim 7, wherein said inhibitor is selected from the group consisting of boronic acids, borinic acids and salts thereof.
9. A process for preparing a detergent composition comprising an enzyme and an enzyme inhibitor, wherein a liquid composition according to any one of claims1-8 is combined with the remaining components of said detergent composition.
10. A process according to claim 9, wherein the detergent composition is a liquid composition.
11. A detergent composition prepared by a process according to claim 9 or 10.
12. Use of a liquid composition according to any one of claims 1-8 in the manufacture of a detergent composition for laundry washing or dishwashing.
13. The use according to claim 12 for the manufacture of a liquid detergent composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK0025/95 | 1995-01-09 | ||
DK2595 | 1995-01-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2208705A1 true CA2208705A1 (en) | 1996-07-18 |
Family
ID=8088898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002208705A Abandoned CA2208705A1 (en) | 1995-01-09 | 1996-01-09 | Stabilization of liquid enzyme compositions |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0802968A1 (en) |
JP (1) | JPH10511855A (en) |
CN (1) | CN1168155A (en) |
AR (1) | AR000649A1 (en) |
AU (1) | AU4328396A (en) |
BR (1) | BR9606684A (en) |
CA (1) | CA2208705A1 (en) |
FI (1) | FI972896A0 (en) |
WO (1) | WO1996021716A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5834415A (en) * | 1994-04-26 | 1998-11-10 | Novo Nordisk A/S | Naphthalene boronic acids |
US7041280B2 (en) | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
US6858592B2 (en) | 2001-06-29 | 2005-02-22 | Genzyme Corporation | Aryl boronic acids for treating obesity |
JP2005520546A (en) | 2002-03-27 | 2005-07-14 | ノボザイムス アクティーゼルスカブ | Granule with filament coating |
CN101048487B (en) * | 2004-10-28 | 2010-05-05 | 诺维信公司 | Laundry bars with improved storage stability |
EP1924677A1 (en) * | 2005-09-02 | 2008-05-28 | Novozymes A/S | Stabilization of concentrated liquid enzyme additives |
US20080025960A1 (en) * | 2006-07-06 | 2008-01-31 | Manoj Kumar | Detergents with stabilized enzyme systems |
DE102007011236A1 (en) | 2007-03-06 | 2008-09-11 | Henkel Ag & Co. Kgaa | Carboxyl-bearing benzophenone or benzoic acid anilide derivatives as enzyme stabilizers |
US10590368B2 (en) | 2007-03-27 | 2020-03-17 | Novozymes A/S | Stable enzyme solutions and method of manufacturing |
DE102007041754A1 (en) | 2007-09-04 | 2009-03-05 | Henkel Ag & Co. Kgaa | Polycyclic compounds as enzyme stabilizers |
DE102007057583A1 (en) | 2007-11-28 | 2009-06-04 | Henkel Ag & Co. Kgaa | Detergents with stabilized enzymes |
US20090209447A1 (en) * | 2008-02-15 | 2009-08-20 | Michelle Meek | Cleaning compositions |
DE102008010429A1 (en) | 2008-02-21 | 2009-08-27 | Henkel Ag & Co. Kgaa | Detergent or cleaning agent, useful for washing and/or cleaning textiles, and/or hard surfaces, comprises a protease, preferably serine-protease, and one urea- or thiourea- derivative, as an enzyme stabilizer |
DE102008014760A1 (en) | 2008-03-18 | 2009-09-24 | Henkel Ag & Co. Kgaa | Imidazolium salts as enzyme stabilizers |
DE102009045064A1 (en) | 2009-09-28 | 2011-03-31 | Henkel Ag & Co. Kgaa | Stabilized enzymatic composition |
US8709489B2 (en) | 2009-09-30 | 2014-04-29 | Surmodics, Inc. | Emulsions containing arylboronic acids and medical articles made therefrom |
DE102010038497A1 (en) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
DE102010038498A1 (en) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
DE102010038502A1 (en) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
DE102010038501A1 (en) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
DE102010038496A1 (en) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
DE102010038499A1 (en) | 2010-07-27 | 2012-02-02 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
DE102010043934A1 (en) | 2010-11-15 | 2012-05-16 | Henkel Ag & Co. Kgaa | Stabilized liquid enzyme-containing surfactant preparation |
DE102011000889A1 (en) * | 2011-02-23 | 2012-08-23 | Witty Chemie Gmbh & Co. Kg | Detergent, useful for dishwashing, and for the machine cleaning of dishes comprises enzymes comprising e.g. amylases, borax, a phosphoric acid ester, a complexing agent, a solubilizer, nonionic surfactants, propylene glycol and water |
PL2535401T3 (en) * | 2011-06-17 | 2017-07-31 | Dalli-Werke Gmbh & Co. Kg | Detergent composition comprising soil-release polymers of improved storage stability |
DE102011118027A1 (en) | 2011-09-12 | 2013-03-14 | Henkel Ag & Co. Kgaa | A method of adapting a hydrolytic enzyme to a hydrolytic enzyme stabilizing component |
WO2013148492A1 (en) | 2012-03-29 | 2013-10-03 | Novozymes A/S | Use of enzymes for preparing water soluble films |
EP2716644B1 (en) | 2012-10-03 | 2017-04-05 | The Procter and Gamble Company | A stable enzyme stabilizer premix |
DE102013202450A1 (en) * | 2013-02-14 | 2014-08-14 | Henkel Ag & Co. Kgaa | Liquid washing or cleaning agent with improved enzyme stability |
US20160024440A1 (en) * | 2013-03-14 | 2016-01-28 | Novozymes A/S | Enzyme and Inhibitor Containing Water-Soluble Films |
ITMI20130782A1 (en) * | 2013-05-13 | 2014-11-14 | Fra Ber S R L | PRODUCTS FOR ENZYMATIC BASED SELF-WASHING |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ237570A (en) * | 1990-04-13 | 1993-09-27 | Colgate Palmolive Co | Enzyme stabilising composition and stabilised enzyme-containing built detergent compositions |
DK204290D0 (en) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | ENZYMATIC DETERGENT COMPOSITION AND PROCEDURE FOR ENZYME STABILIZATION |
JP3244700B2 (en) * | 1991-12-04 | 2002-01-07 | ザ、プロクター、エンド、ギャンブル、カンパニー | Liquid laundry detergent containing boric acid-diol complex that inhibits citric acid, cellulase, and proteolytic enzymes |
-
1996
- 1996-01-09 CA CA002208705A patent/CA2208705A1/en not_active Abandoned
- 1996-01-09 BR BR9606684A patent/BR9606684A/en not_active Application Discontinuation
- 1996-01-09 AR AR33497096A patent/AR000649A1/en unknown
- 1996-01-09 AU AU43283/96A patent/AU4328396A/en not_active Abandoned
- 1996-01-09 EP EP96900086A patent/EP0802968A1/en not_active Withdrawn
- 1996-01-09 WO PCT/DK1996/000005 patent/WO1996021716A1/en not_active Application Discontinuation
- 1996-01-09 CN CN 96191382 patent/CN1168155A/en active Pending
- 1996-01-09 JP JP8521371A patent/JPH10511855A/en active Pending
-
1997
- 1997-07-08 FI FI972896A patent/FI972896A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0802968A1 (en) | 1997-10-29 |
FI972896A (en) | 1997-07-08 |
MX9705165A (en) | 1997-10-31 |
BR9606684A (en) | 1998-06-09 |
CN1168155A (en) | 1997-12-17 |
AR000649A1 (en) | 1997-07-10 |
FI972896A0 (en) | 1997-07-08 |
JPH10511855A (en) | 1998-11-17 |
WO1996021716A1 (en) | 1996-07-18 |
AU4328396A (en) | 1996-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2208705A1 (en) | Stabilization of liquid enzyme compositions | |
US5834415A (en) | Naphthalene boronic acids | |
US5972873A (en) | 4-substituted-phenyl-boronic acids as enzyme stabilizers | |
US5968887A (en) | Boronic acid or borinic acid derivatives as enzyme stabilizers | |
US11827866B2 (en) | Stable enzyme solutions and method of manufacturing | |
EP0425214A2 (en) | Enzyme-containing detergent compositions and their use | |
JP2010538138A (en) | Polycyclic compounds as enzyme stabilizers | |
MXPA97005165A (en) | Stabilization of liquid compositions of enzi | |
MXPA97009823A (en) | Fenilboronic acids 4-substituted stabilizers of enzi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20020109 |